| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 3.22e-13 | 9 | 200 | 7 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 3.22e-13 | 9 | 200 | 7 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.06e-12 | 10 | 200 | 7 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.06e-12 | 10 | 200 | 7 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.06e-12 | 10 | 200 | 7 | GO:0046977 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER MMD2 DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 2.17e-12 | 600 | 200 | 29 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK GK GK2 NUAK1 FER MMD2 DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 4.69e-12 | 709 | 200 | 31 | GO:0016773 |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 6.91e-12 | 12 | 200 | 7 | GO:0030881 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 NUAK2 TNNI3K CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 1.62e-11 | 363 | 200 | 22 | GO:0106310 |
| GeneOntologyMolecularFunction | kinase activity | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK GK GK2 NUAK1 FER MMD2 DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 3.13e-11 | 764 | 200 | 31 | GO:0016301 |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.63e-10 | 17 | 200 | 7 | GO:0046703 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL13RA2 IGSF6 EPHA6 OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 GHR PTPRF PTPRH OPN5 GPRC5D TACR1 ADGRL3 TBXA2R OR51A4 OR51A2 PLXNA3 GPBAR1 VIPR2 FLT4 HTR5A HTR6 OR5D18 FFAR3 NTRK3 OR2J1 TEK TIE1 GPR156 CD300LG HRH4 ADGRE5 LGR6 GPR119 HRH3 OR5D13 OR2W6P | 4.99e-10 | 1353 | 200 | 40 | GO:0004888 |
| GeneOntologyMolecularFunction | T cell receptor binding | 6.32e-10 | 20 | 200 | 7 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 7.54e-10 | 32 | 200 | 8 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 NUAK2 TNNI3K CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 8.26e-10 | 446 | 200 | 22 | GO:0004674 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK GK GK2 NUAK1 FER MMD2 DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 4.63e-09 | 938 | 200 | 31 | GO:0016772 |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.76e-09 | 42 | 200 | 8 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.79e-08 | 49 | 200 | 8 | GO:0042605 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 GPRC5D TACR1 ADGRL3 TBXA2R OR51A4 OR51A2 GPBAR1 VIPR2 HTR5A HTR6 OR5D18 FFAR3 OR2J1 GPR156 HRH4 ADGRE5 LGR6 GPR119 HRH3 OR5D13 OR2W6P | 6.87e-08 | 884 | 200 | 28 | GO:0004930 |
| GeneOntologyMolecularFunction | MHC protein binding | 1.10e-07 | 58 | 200 | 8 | GO:0042287 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC46A1 CLCN3 CLCN6 SLC17A7 SLC16A9 SLC6A15 SLC7A8 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 1.82e-06 | 296 | 200 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.07e-06 | 145 | 200 | 10 | GO:0004713 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.20e-06 | 22 | 200 | 5 | GO:0004993 | |
| GeneOntologyMolecularFunction | symporter activity | SLC46A1 SLC17A7 SLC16A9 SLC6A15 SLC6A11 SLC10A2 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 2.81e-06 | 150 | 200 | 10 | GO:0015293 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 3.15e-06 | 41 | 200 | 6 | GO:0008227 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | PRSS8 KLK10 CTSC TMPRSS5 DPP8 PLAT PLAU CELA3B PRSS47P HABP2 KLK13 | 8.01e-06 | 207 | 200 | 11 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | PRSS8 KLK10 CTSC TMPRSS5 DPP8 PLAT PLAU CELA3B PRSS47P HABP2 KLK13 | 1.00e-05 | 212 | 200 | 11 | GO:0017171 |
| GeneOntologyMolecularFunction | histamine receptor activity | 1.94e-05 | 6 | 200 | 3 | GO:0004969 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | PRSS8 KLK10 CTSC TMPRSS5 PLAT PLAU CELA3B PRSS47P HABP2 KLK13 | 2.26e-05 | 190 | 200 | 10 | GO:0004252 |
| GeneOntologyMolecularFunction | antigen binding | 2.26e-05 | 190 | 200 | 10 | GO:0003823 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A1 CLCN3 CLCN6 SLC17A7 SLC16A9 CYB561D2 ATP13A5 SLC6A15 SLC7A8 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 2.64e-05 | 477 | 200 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC46A1 SLC17A7 SLC6A15 SLC6A11 SLC10A2 SLC45A3 SLC20A2 SLC39A14 | 2.67e-05 | 119 | 200 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 3.36e-05 | 7 | 200 | 3 | GO:0016907 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 1.05e-04 | 47 | 200 | 5 | GO:0004712 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 1.54e-04 | 11 | 200 | 3 | GO:0004301 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 2.04e-04 | 12 | 200 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 2.24e-04 | 161 | 200 | 8 | GO:0051087 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 2.63e-04 | 13 | 200 | 3 | GO:0099528 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 2.63e-04 | 13 | 200 | 3 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 2.63e-04 | 13 | 200 | 3 | GO:0016803 | |
| GeneOntologyMolecularFunction | glycerol kinase activity | 2.97e-04 | 3 | 200 | 2 | GO:0004370 | |
| GeneOntologyMolecularFunction | cadmium ion transmembrane transporter activity | 2.97e-04 | 3 | 200 | 2 | GO:0015086 | |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 2.97e-04 | 3 | 200 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 2.97e-04 | 3 | 200 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.86e-04 | 65 | 200 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC46A1 SLC17A7 ATP13A5 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 | 9.47e-04 | 301 | 200 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPC3 BEST3 SLC46A1 CLCN3 CLCN6 SCN4A SLC17A7 CACNA2D1 TMEM175 ATP13A5 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 KCNAB3 | 1.07e-03 | 793 | 200 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.33e-03 | 81 | 200 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | peptide binding | CLSTN3 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H FFAR4 SLC7A8 | 1.43e-03 | 318 | 200 | 10 | GO:0042277 |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.51e-03 | 23 | 200 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.64e-03 | 85 | 200 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPC3 BEST3 SLC46A1 CLCN3 CLCN6 SCN4A SLC17A7 CACNA2D1 TMEM175 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 KCNAB3 | 1.67e-03 | 758 | 200 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPC3 BEST3 SLC46A1 CLCN3 CLCN6 SCN4A SLC17A7 SLC22A20P CACNA2D1 SLC16A9 CYB561D2 TMEM175 ATP13A5 SLC6A15 SLC7A8 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 KCNAB3 | 1.73e-03 | 1180 | 200 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.43e-03 | 27 | 200 | 3 | GO:0004683 | |
| GeneOntologyMolecularFunction | transporter activity | TRPC3 BEST3 SLC46A1 CLCN3 CLCN6 SCN4A SLC17A7 GM2A SLC22A20P CACNA2D1 SLC16A9 CYB561D2 TMEM175 ATP13A5 SLC6A15 SLC7A8 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 KCNAB3 | 2.50e-03 | 1289 | 200 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPC3 SCN4A SLC17A7 CACNA2D1 TMEM175 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC20A2 SLC39A14 KCNAB3 | 2.63e-03 | 465 | 200 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC46A1 SLC17A7 SLC22A20P SLC16A9 SLC6A15 SLC7A8 SLC6A11 SLC10A2 SLC39A14 | 2.87e-03 | 293 | 200 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPC3 SLC46A1 SCN4A SLC17A7 CACNA2D1 TMEM175 ATP13A5 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 KCNAB3 | 2.90e-03 | 664 | 200 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.35e-03 | 100 | 200 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.96e-03 | 32 | 200 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 4.15e-03 | 310 | 200 | 9 | GO:0030246 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PRSS8 KLK10 GPAA1 CTSC TMPRSS5 PLAT PLAU CELA3B PRSS47P HABP2 KLK13 | 4.18e-03 | 430 | 200 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.20e-03 | 151 | 200 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | branched-chain amino acid transmembrane transporter activity | 4.26e-03 | 10 | 200 | 2 | GO:0015658 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 4.26e-03 | 10 | 200 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPC3 SLC46A1 SCN4A SLC17A7 CACNA2D1 TMEM175 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 KCNAB3 | 4.40e-03 | 627 | 200 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.94e-03 | 207 | 200 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.07e-03 | 208 | 200 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.12e-03 | 35 | 200 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 5.17e-03 | 11 | 200 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 5.17e-03 | 11 | 200 | 2 | GO:0005381 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 5.17e-14 | 8 | 197 | 7 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 6.93e-11 | 16 | 197 | 7 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.17e-10 | 17 | 197 | 7 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.17e-10 | 17 | 197 | 7 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.90e-10 | 18 | 197 | 7 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.90e-10 | 18 | 197 | 7 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.40e-09 | 23 | 197 | 7 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.71e-09 | 25 | 197 | 7 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.71e-09 | 25 | 197 | 7 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.79e-08 | 32 | 197 | 7 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.11e-07 | 41 | 197 | 7 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.32e-07 | 42 | 197 | 7 | GO:0001916 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | MARK3 PDPK1 TTK DYRK3 DYRK2 EPM2A CAMK2A NTRK3 CAMK1G TEK CHEK2 PNCK MAP3K13 ULK2 DCLK1 | 2.82e-07 | 307 | 197 | 15 | GO:0018105 |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 3.42e-07 | 70 | 197 | 8 | GO:0001913 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 3.44e-07 | 48 | 197 | 7 | GO:0002478 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | MARK3 PDPK1 TTK DYRK3 DYRK2 EPM2A CAMK2A NTRK3 CAMK1G TEK CHEK2 PNCK MAP3K13 ULK2 DCLK1 | 4.59e-07 | 319 | 197 | 15 | GO:0018209 |
| GeneOntologyBiologicalProcess | T cell mediated immunity | HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H RFTN1 SLC11A1 CD8A | 4.94e-07 | 163 | 197 | 11 | GO:0002456 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 6.50e-07 | 76 | 197 | 8 | GO:0048002 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 6.93e-07 | 53 | 197 | 7 | GO:0001914 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | GPR101 CHRM2 FFAR4 ADGRL3 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 FFAR3 HRH4 ADGRE5 GPR119 HRH3 | 6.95e-07 | 286 | 197 | 14 | GO:0007188 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 8.77e-07 | 79 | 197 | 8 | GO:0001912 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H RFTN1 SLC11A1 CD8A | 9.21e-07 | 139 | 197 | 10 | GO:0019882 |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 9.80e-07 | 9 | 197 | 4 | GO:0042270 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.30e-06 | 58 | 197 | 7 | GO:0019884 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 2.01e-06 | 88 | 197 | 8 | GO:0031343 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.21e-06 | 23 | 197 | 5 | GO:0098664 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 3.41e-06 | 4 | 197 | 3 | GO:0002488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 3.41e-06 | 4 | 197 | 3 | GO:0002489 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 6.83e-06 | 74 | 197 | 7 | GO:0002711 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | IL13RA2 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H IGLL5 SVEP1 RFTN1 AP1G1 SLC11A1 CD8A SLAMF7 | 6.99e-06 | 449 | 197 | 16 | GO:0002449 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 8.46e-06 | 5 | 197 | 3 | GO:0002481 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 8.46e-06 | 5 | 197 | 3 | GO:0002477 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 GPRC5D TACR1 ADGRL3 TBXA2R OR51A4 OR51A2 GPBAR1 VIPR2 HTR5A HTR6 OR5D18 CAMK2A FFAR3 OR2J1 CRY1 GPR156 HRH4 ADGRE5 LGR6 SLC39A14 GPR119 HRH3 OR5D13 OR2W6P | 9.23e-06 | 1395 | 197 | 31 | GO:0007186 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | MARK3 PDPK1 CLK4 SIK1 TTK FER FLT4 CAMK2A CHEK2 MAP3K13 ULK2 | 1.28e-05 | 228 | 197 | 11 | GO:0046777 |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 1.31e-05 | 187 | 197 | 10 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H PTPRF CEP97 PLXNA3 ULK2 | 1.57e-05 | 233 | 197 | 11 | GO:0031345 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.57e-05 | 124 | 197 | 8 | GO:0001910 | |
| GeneOntologyBiologicalProcess | neuron projection extension | CLSTN3 PLXNA3 NRCAM JADE2 NTRK3 BCAN MEGF8 MAP3K13 ULK2 DCLK1 | 3.15e-05 | 207 | 197 | 10 | GO:1990138 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 3.69e-05 | 169 | 197 | 9 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.79e-05 | 40 | 197 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 3.79e-05 | 96 | 197 | 7 | GO:0002704 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | IL13RA2 HLA-A HLA-B HLA-C PDPK1 CTSC HLA-E HLA-F HLA-G HLA-H IGLL5 SVEP1 RFTN1 AP1G1 SLC11A1 CD8A SLAMF7 | 4.06e-05 | 576 | 197 | 17 | GO:0002443 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.28e-05 | 41 | 197 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | 4.64e-05 | 8 | 197 | 3 | GO:0007197 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | PRSS8 PDPK1 TRPC3 BEST3 SIK1 SLC46A1 SLC35G1 CLCN3 CLCN6 SCN4A SLC17A7 MLLT6 SLC22A20P NOS3 TCAF2 CACNA2D1 EPM2A CAMK2A TMEM175 ATP13A5 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC20A2 UBR3 SLC39A14 KCNAB3 HRH3 | 4.76e-05 | 1374 | 197 | 29 | GO:0006811 |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H AP1G1 FER FFAR3 TEK FCN3 | 5.68e-05 | 317 | 197 | 12 | GO:0002699 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | MARK3 PDPK1 CLK4 GCSH TTK GHR FER DYRK3 DYRK2 FLT4 EPM2A CAMK2A NTRK3 CAMK1G LRRK1 TEK PRKAA2 CHEK2 PNCK CSKMT MAP3K13 ULK2 DCLK1 | 6.14e-05 | 976 | 197 | 23 | GO:0018193 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 6.73e-05 | 105 | 197 | 7 | GO:0042267 | |
| GeneOntologyBiologicalProcess | immune effector process | IL13RA2 HLA-A HLA-B HLA-C PDPK1 CTSC HLA-E HLA-F HLA-G HLA-H IGLL5 SVEP1 RFTN1 AP1G1 FER FFAR3 TEK FCN3 SLC11A1 CD8A SLAMF7 | 7.82e-05 | 859 | 197 | 21 | GO:0002252 |
| GeneOntologyBiologicalProcess | organic cation transport | 7.83e-05 | 145 | 197 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 8.37e-05 | 47 | 197 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 8.54e-05 | 109 | 197 | 7 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 8.62e-05 | 147 | 197 | 8 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 8.82e-05 | 76 | 197 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | IL13RA2 HLA-A HLA-B HLA-C PDPK1 HLA-E HLA-F HLA-G HLA-H SVEP1 AP1G1 FER FFAR3 TEK FCN3 | 9.10e-05 | 497 | 197 | 15 | GO:0002697 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 9.57e-05 | 111 | 197 | 7 | GO:0002709 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.93e-05 | 150 | 197 | 8 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 9.93e-05 | 150 | 197 | 8 | GO:0002708 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.18e-04 | 80 | 197 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell cytokine production | 1.34e-04 | 11 | 197 | 3 | GO:0002729 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.36e-04 | 52 | 197 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.44e-04 | 83 | 197 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.49e-04 | 159 | 197 | 8 | GO:0002821 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | IL13RA2 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H IGLL5 SVEP1 RFTN1 SLC11A1 CD8A | 1.50e-04 | 462 | 197 | 14 | GO:0002460 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SVEP1 ALOX15 SLC11A1 | 1.62e-04 | 252 | 197 | 10 | GO:0002819 |
| GeneOntologyBiologicalProcess | developmental growth | CLSTN3 HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR PLAU PLXNA3 NRCAM JADE2 NTRK3 COX10 BCAN SIK3 MEGF8 MAP3K13 LGR6 ULK2 DCLK1 | 1.77e-04 | 911 | 197 | 21 | GO:0048589 |
| GeneOntologyBiologicalProcess | natural killer cell cytokine production | 1.77e-04 | 12 | 197 | 3 | GO:0002370 | |
| GeneOntologyBiologicalProcess | alditol phosphate metabolic process | 1.77e-04 | 12 | 197 | 3 | GO:0052646 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell cytokine production | 1.77e-04 | 12 | 197 | 3 | GO:0002727 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | IL13RA2 HLA-A HLA-B HLA-C PDPK1 HLA-E HLA-F HLA-G HLA-H SVEP1 AP1G1 | 1.98e-04 | 309 | 197 | 11 | GO:0002703 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 2.00e-04 | 166 | 197 | 8 | GO:0002698 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC46A1 SLC17A7 EPM2A SLC16A9 SLC6A15 SLC7A8 SLC6A11 SLC11A1 | 2.08e-04 | 167 | 197 | 8 | GO:1903825 |
| GeneOntologyBiologicalProcess | metal ion transport | PRSS8 PDPK1 TRPC3 SIK1 SLC46A1 SLC35G1 SCN4A SLC17A7 MLLT6 NOS3 CACNA2D1 EPM2A CAMK2A TMEM175 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC20A2 UBR3 SLC39A14 KCNAB3 | 2.37e-04 | 1000 | 197 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | glycerol-3-phosphate biosynthetic process | 2.71e-04 | 3 | 197 | 2 | GO:0046167 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CUL7 METRN PTPRF PLXNA3 NRCAM NTRK3 MEGF8 MAP3K13 ULK2 | 2.74e-04 | 612 | 197 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 2.86e-04 | 175 | 197 | 8 | GO:0002705 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 2.91e-04 | 61 | 197 | 5 | GO:0007187 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | PRSS8 PDPK1 TRPC3 SIK1 SLC46A1 SLC35G1 CLCN3 SCN4A SLC17A7 MLLT6 NOS3 CACNA2D1 EPM2A CAMK2A TMEM175 ATP13A5 SLC6A15 SLC6A11 SLC10A2 SLC11A1 SLC20A2 UBR3 SLC39A14 KCNAB3 | 2.92e-04 | 1157 | 197 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | axon extension | 3.22e-04 | 135 | 197 | 7 | GO:0048675 | |
| GeneOntologyBiologicalProcess | sodium ion transport | PRSS8 SIK1 SCN4A SLC17A7 MLLT6 NOS3 SLC6A15 SLC6A11 SLC10A2 SLC20A2 | 3.26e-04 | 275 | 197 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production involved in immune response | 3.77e-04 | 99 | 197 | 6 | GO:0002720 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 4.06e-04 | 232 | 197 | 9 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.46e-04 | 235 | 197 | 9 | GO:0002822 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 5.14e-04 | 191 | 197 | 8 | GO:0007189 | |
| GeneOntologyBiologicalProcess | neuron projection development | CLSTN3 EPHA6 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CUL7 KIRREL3 METRN PTPRF PLXNA3 NRCAM JADE2 CAMK2A NTRK3 BCAN TECTA MEGF8 MAP3K13 LGR6 ULK2 DCLK1 | 5.63e-04 | 1285 | 197 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 5.64e-04 | 40 | 197 | 4 | GO:0045954 | |
| GeneOntologyBiologicalProcess | amino acid transport | 5.89e-04 | 195 | 197 | 8 | GO:0006865 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | CLSTN3 PLXNA3 NRCAM JADE2 NTRK3 BCAN MEGF8 MAP3K13 ULK2 DCLK1 | 6.27e-04 | 299 | 197 | 10 | GO:0060560 |
| GeneOntologyBiologicalProcess | developmental cell growth | CLSTN3 PLXNA3 NRCAM JADE2 NTRK3 BCAN MEGF8 MAP3K13 ULK2 DCLK1 | 6.60e-04 | 301 | 197 | 10 | GO:0048588 |
| GeneOntologyBiologicalProcess | multicellular organism growth | 6.75e-04 | 249 | 197 | 9 | GO:0035264 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | CLSTN3 CUL7 METRN PTPRF ADGRL3 PLXNA3 JADE2 NTRK3 BCAN MEGF8 ADGRE5 MAP3K13 | 7.17e-04 | 418 | 197 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | growth | CLSTN3 HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR RFTN1 PLAU PLXNA3 FLT4 EPM2A NRCAM JADE2 NTRK3 COX10 BCAN SIK3 MEGF8 MAP3K13 LGR6 ULK2 DCLK1 | 7.41e-04 | 1235 | 197 | 24 | GO:0040007 |
| GeneOntologyBiologicalProcess | cell killing | 7.68e-04 | 307 | 197 | 10 | GO:0001906 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 8.13e-04 | 44 | 197 | 4 | GO:0002717 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell degranulation | 8.91e-04 | 5 | 197 | 2 | GO:0043323 | |
| GeneOntologyBiologicalProcess | Tie signaling pathway | 8.91e-04 | 5 | 197 | 2 | GO:0048014 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell proliferation | 8.91e-04 | 5 | 197 | 2 | GO:2000566 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | NEB SVEP1 CLCN3 CLCN6 FER TACR1 NOS3 ALOX15 TBXA2R PLXNA3 NRCAM NTRK3 MEGF8 MAP3K13 ULK2 | 9.11e-04 | 618 | 197 | 15 | GO:0090066 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 9.90e-04 | 163 | 197 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.04e-03 | 120 | 197 | 6 | GO:0003333 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 6.37e-15 | 7 | 199 | 7 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 7.47e-13 | 10 | 199 | 7 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.07e-11 | 14 | 199 | 7 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.14e-10 | 17 | 199 | 7 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.37e-09 | 23 | 199 | 7 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 3.60e-09 | 26 | 199 | 7 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.42e-08 | 35 | 199 | 7 | GO:0098553 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 9.59e-08 | 83 | 199 | 9 | GO:0030670 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.30e-07 | 42 | 199 | 7 | GO:0070971 | |
| GeneOntologyCellularComponent | external side of plasma membrane | IL13RA2 PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR CLCN3 BTNL3 PLAU NRCAM FCN3 CD8A ADGRE5 SLAMF7 BTNL9 PDCD1LG2 | 1.31e-07 | 519 | 199 | 20 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | IL13RA2 PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR CLCN3 BTNL3 FER GM2A PLAU ALOX15 EPM2A NRCAM BCAN TECTA FCN3 CD8A ADGRE5 SLAMF7 BTNL9 PDCD1LG2 | 2.74e-07 | 875 | 199 | 26 | GO:0098552 |
| GeneOntologyCellularComponent | lumenal side of membrane | 3.37e-07 | 48 | 199 | 7 | GO:0098576 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H CHRM2 NOS3 CAMK2A SLC11A1 | 9.46e-07 | 212 | 199 | 12 | GO:0030666 |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.50e-06 | 64 | 199 | 7 | GO:0012507 | |
| GeneOntologyCellularComponent | phagocytic vesicle | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H CLCN3 SLC11A1 | 2.71e-06 | 157 | 199 | 10 | GO:0045335 |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.16e-06 | 125 | 199 | 9 | GO:0140534 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.05e-05 | 110 | 199 | 8 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.20e-05 | 112 | 199 | 8 | GO:0055038 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.68e-05 | 85 | 199 | 7 | GO:0005801 | |
| GeneOntologyCellularComponent | endocytic vesicle | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H CHRM2 FFAR4 CLCN3 NOS3 CAMK2A SLC11A1 | 2.00e-05 | 384 | 199 | 14 | GO:0030139 |
| GeneOntologyCellularComponent | cell surface | IL13RA2 CLSTN3 PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SLC46A1 GHR CLCN3 BTNL3 PLAT PLAU TACR1 NRCAM BCAN TEK FCN3 CD8A ADGRE5 SLAMF7 BTNL9 PDCD1LG2 | 2.10e-05 | 1111 | 199 | 26 | GO:0009986 |
| GeneOntologyCellularComponent | early endosome membrane | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H CLCN3 SLC39A14 | 3.76e-05 | 212 | 199 | 10 | GO:0031901 |
| GeneOntologyCellularComponent | coated vesicle membrane | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CHRM2 AP1G1 SLC17A7 | 4.24e-05 | 215 | 199 | 10 | GO:0030662 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H SLC46A1 CHRM2 FFAR4 CLCN3 CLCN6 AP1G1 SLC17A7 PLAU NOS3 CAMK2A CYB561D2 TMEM175 ATP13A5 SLC35G2 SLC11A1 LHFPL2 CD300LG ADGRE5 SLC39A14 ULK2 | 4.79e-05 | 1307 | 199 | 28 | GO:0030659 |
| GeneOntologyCellularComponent | recycling endosome | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CLCN3 AP1G1 DENND6B | 5.55e-05 | 222 | 199 | 10 | GO:0055037 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H SLC46A1 CHRM2 FFAR4 CLCN3 CLCN6 AP1G1 SLC17A7 PLAU NOS3 CAMK2A CYB561D2 TMEM175 ATP13A5 SLC35G2 SLC11A1 LHFPL2 CD300LG ADGRE5 SLC39A14 ULK2 | 6.08e-05 | 1325 | 199 | 28 | GO:0012506 |
| GeneOntologyCellularComponent | endosome membrane | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H SLC46A1 FFAR4 CLCN3 CLCN6 TMEM175 ATP13A5 SLC11A1 CD300LG SLC39A14 | 6.74e-05 | 602 | 199 | 17 | GO:0010008 |
| GeneOntologyCellularComponent | transport vesicle membrane | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CLCN3 AP1G1 SLC17A7 SLC35G2 | 1.21e-04 | 293 | 199 | 11 | GO:0030658 |
| GeneOntologyCellularComponent | postsynaptic membrane | CLSTN3 CSMD2 CHRM2 CLCN3 PTPRF ADGRL3 CACNA2D1 NRCAM HTR5A NTRK3 SLC6A11 SSPN GPR156 | 1.43e-04 | 405 | 199 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | lysosomal membrane | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 AP1G1 TMEM175 SLC11A1 SLC39A14 | 1.45e-04 | 462 | 199 | 14 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 AP1G1 TMEM175 SLC11A1 SLC39A14 | 1.45e-04 | 462 | 199 | 14 | GO:0098852 |
| GeneOntologyCellularComponent | membrane raft | PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H RFTN1 NOS3 TEK CD8A | 1.92e-04 | 362 | 199 | 12 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H RFTN1 NOS3 TEK CD8A | 2.02e-04 | 364 | 199 | 12 | GO:0098857 |
| GeneOntologyCellularComponent | lysosome | MAN2B1 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 SULT1C2 AP1G1 GM2A TMEM175 BCAN SLC11A1 SLC39A14 | 2.86e-04 | 811 | 199 | 19 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MAN2B1 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 SULT1C2 AP1G1 GM2A TMEM175 BCAN SLC11A1 SLC39A14 | 2.86e-04 | 811 | 199 | 19 | GO:0000323 |
| GeneOntologyCellularComponent | Golgi cisterna | 3.16e-04 | 135 | 199 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | vacuolar membrane | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 AP1G1 TMEM175 SLC11A1 SLC39A14 | 3.74e-04 | 507 | 199 | 14 | GO:0005774 |
| GeneOntologyCellularComponent | vacuole | MAN2B1 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H FFAR4 CLCN3 CLCN6 SULT1C2 AP1G1 GM2A TMEM175 BCAN SLC11A1 SLC39A14 ULK2 | 4.68e-04 | 913 | 199 | 20 | GO:0005773 |
| GeneOntologyCellularComponent | coated vesicle | HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H CHRM2 AP1G1 SLC17A7 | 7.00e-04 | 360 | 199 | 11 | GO:0030135 |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 8.85e-04 | 5 | 199 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | Golgi stack | 1.28e-03 | 171 | 199 | 7 | GO:0005795 | |
| GeneOntologyCellularComponent | serine protease inhibitor complex | 1.32e-03 | 6 | 199 | 2 | GO:0097180 | |
| GeneOntologyCellularComponent | receptor complex | IL13RA2 GPR101 GHR GPRC5D PLXNA3 GPBAR1 FLT4 NTRK3 TEK CD8A TIE1 TRBV5-3 GPR156 GPR119 | 1.40e-03 | 581 | 199 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | synaptic membrane | CLSTN3 CSMD2 CHRM2 CLCN3 PTPRF ADGRL3 CACNA2D1 NRCAM HTR5A NTRK3 BCAN SLC6A11 SSPN GPR156 | 1.45e-03 | 583 | 199 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | transport vesicle | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H KIRREL3 CLCN3 AP1G1 SLC17A7 SLC35G2 SSPN | 1.47e-03 | 519 | 199 | 13 | GO:0030133 |
| GeneOntologyCellularComponent | early endosome | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H RFTN1 CLCN3 AP1G1 SLC39A14 | 2.29e-03 | 481 | 199 | 12 | GO:0005769 |
| GeneOntologyCellularComponent | protease inhibitor complex | 2.43e-03 | 8 | 199 | 2 | GO:0097179 | |
| GeneOntologyCellularComponent | endosome | HLA-A HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H SLC46A1 FFAR4 RFTN1 CLCN3 PTPRF CLCN6 AP1G1 DENND6B TMEM175 ATP13A5 SLC11A1 CD300LG SLC39A14 | 3.84e-03 | 1167 | 199 | 21 | GO:0005768 |
| GeneOntologyCellularComponent | apical part of cell | SLC46A1 CLCN3 PTPRH GM2A PLAT NOS3 TEK SLC7A8 SLC10A2 SLC20A2 PRKAA2 CD300LG SLC39A14 | 4.53e-03 | 592 | 199 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | peptidase inhibitor complex | 4.69e-03 | 11 | 199 | 2 | GO:1904090 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.56e-03 | 13 | 199 | 2 | GO:1990907 | |
| MousePheno | spinal cord inflammation | 1.87e-13 | 8 | 161 | 7 | MP:0030987 | |
| MousePheno | decreased mature NK cell number | 6.75e-10 | 18 | 161 | 7 | MP:0013672 | |
| MousePheno | decreased immature NK cell number | 5.92e-09 | 14 | 161 | 6 | MP:0013666 | |
| MousePheno | abnormal mature NK cell number | 6.92e-09 | 24 | 161 | 7 | MP:0013671 | |
| MousePheno | abnormal mature NK cell morphology | 9.52e-09 | 25 | 161 | 7 | MP:0013700 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 3.90e-08 | 45 | 161 | 8 | MP:0004804 | |
| MousePheno | abnormal immature NK cell number | 5.10e-08 | 19 | 161 | 6 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 5.10e-08 | 19 | 161 | 6 | MP:0013699 | |
| MousePheno | decreased gamma-delta T cell number | 5.58e-08 | 47 | 161 | 8 | MP:0008347 | |
| MousePheno | cystolithiasis | 1.36e-07 | 22 | 161 | 6 | MP:0011625 | |
| MousePheno | abnormal gamma-delta T cell number | 1.20e-06 | 69 | 161 | 8 | MP:0008345 | |
| MousePheno | urolithiasis | 1.23e-06 | 31 | 161 | 6 | MP:0005360 | |
| MousePheno | CNS inflammation | 2.65e-06 | 54 | 161 | 7 | MP:0006082 | |
| MousePheno | abnormal gamma-delta T cell morphology | 3.08e-06 | 78 | 161 | 8 | MP:0008343 | |
| MousePheno | demyelination | 5.90e-06 | 85 | 161 | 8 | MP:0000921 | |
| MousePheno | decreased susceptibility to autoimmune disorder | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR RFTN1 PLAU HRH3 | 7.43e-06 | 180 | 161 | 11 | MP:0005351 |
| MousePheno | increased NK cell number | 4.35e-05 | 82 | 161 | 7 | MP:0008044 | |
| MousePheno | abnormal memory T cell physiology | 4.57e-05 | 18 | 161 | 4 | MP:0008051 | |
| MousePheno | increased alpha-beta T cell number | KLK10 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H EPM2A SIK3 CD8A CDK6 PDCD1LG2 | 6.36e-05 | 311 | 161 | 13 | MP:0012764 |
| MousePheno | decreased alpha-beta T cell number | HLA-A HLA-B HLA-C MARCHF6 HLA-E HLA-F HLA-G HLA-H AP1G1 SIK3 CD8A CDK6 PDCD1LG2 | 7.25e-05 | 315 | 161 | 13 | MP:0012765 |
| MousePheno | decreased NK cell number | 7.33e-05 | 120 | 161 | 8 | MP:0008045 | |
| MousePheno | decreased macrophage nitric oxide production | 1.20e-04 | 9 | 161 | 3 | MP:0011077 | |
| MousePheno | decreased activated T cell number | 1.20e-04 | 9 | 161 | 3 | MP:0001830 | |
| MousePheno | abnormal CD8-positive, alpha beta T cell morphology | KLK10 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H BTNL3 EPM2A SIK3 CD8A CDK6 PDCD1LG2 | 1.24e-04 | 379 | 161 | 14 | MP:0005010 |
| MousePheno | abnormal myelination | 1.29e-04 | 166 | 161 | 9 | MP:0000920 | |
| MousePheno | abnormal maxillary nerve morphology | 1.32e-04 | 2 | 161 | 2 | MP:0009799 | |
| MousePheno | decreased CD8-positive, alpha-beta T cell number | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CD8A CDK6 PDCD1LG2 | 2.16e-04 | 218 | 161 | 10 | MP:0008079 |
| MousePheno | abnormal CD8-positive, alpha-beta T cell number | KLK10 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H EPM2A SIK3 CD8A CDK6 PDCD1LG2 | 2.19e-04 | 352 | 161 | 13 | MP:0008077 |
| MousePheno | abnormal susceptibility to autoimmune disorder | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H GHR RFTN1 PLAU HRH3 PDCD1LG2 | 2.29e-04 | 307 | 161 | 12 | MP:0002425 |
| MousePheno | abnormal cytotoxic T cell physiology | 2.95e-04 | 79 | 161 | 6 | MP:0005078 | |
| MousePheno | abnormal effector T cell morphology | KLK10 HLA-A HLA-B HLA-C MARCHF6 HLA-E HLA-F HLA-G HLA-H RFTN1 AP1G1 BTNL3 EPM2A SIK3 CD8A TLE4 CDK6 PDCD1LG2 | 3.38e-04 | 629 | 161 | 18 | MP:0002435 |
| MousePheno | reduced thrombolysis | 3.93e-04 | 3 | 161 | 2 | MP:0003423 | |
| MousePheno | abnormal macrophage nitric oxide production | 3.94e-04 | 13 | 161 | 3 | MP:0011074 | |
| MousePheno | abnormal alpha-beta T cell morphology | KLK10 HLA-A HLA-B HLA-C MARCHF6 HLA-E HLA-F HLA-G HLA-H RFTN1 AP1G1 BTNL3 EPM2A SIK3 CD8A TLE4 CDK6 PDCD1LG2 | 4.16e-04 | 640 | 161 | 18 | MP:0012762 |
| MousePheno | increased CD4-positive, alpha-beta T cell number | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SIK3 CDK6 PDCD1LG2 | 4.81e-04 | 241 | 161 | 10 | MP:0008074 |
| MousePheno | abnormal alpha-beta T cell number | KLK10 HLA-A HLA-B HLA-C MARCHF6 HLA-E HLA-F HLA-G HLA-H AP1G1 EPM2A SIK3 CD8A TLE4 CDK6 PDCD1LG2 | 5.23e-04 | 542 | 161 | 16 | MP:0012763 |
| MousePheno | abnormal CD4-positive, alpha beta T cell morphology | HLA-A HLA-B HLA-C MARCHF6 HLA-E HLA-F HLA-G HLA-H RFTN1 AP1G1 SIK3 CD8A CDK6 PDCD1LG2 | 5.31e-04 | 437 | 161 | 14 | MP:0002432 |
| MousePheno | abnormal lymphangiogenesis | 6.16e-04 | 15 | 161 | 3 | MP:0008778 | |
| Domain | PROTEIN_KINASE_ATP | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 5.59e-14 | 459 | 196 | 28 | PS00107 |
| Domain | Protein_kinase_ATP_BS | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 PNCK ULK2 DCLK1 CDK6 | 2.45e-13 | 379 | 196 | 25 | IPR017441 |
| Domain | Prot_kinase_dom | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 2.66e-13 | 489 | 196 | 28 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 3.24e-13 | 493 | 196 | 28 | PS50011 |
| Domain | MHC_I_a_C | 1.24e-12 | 6 | 196 | 6 | IPR010579 | |
| Domain | MHC_I_C | 1.24e-12 | 6 | 196 | 6 | PF06623 | |
| Domain | Ig-like_fold | IL13RA2 IGSF6 EPHA6 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H KIRREL2 IGLL5 GHR KIRREL3 PTPRF PTPRH BTNL3 PLXNA3 LRIT2 FLT4 EPM2A NRCAM NTRK3 TRIM71 BCAN TEK CD8A TIE1 CD300LG SLAMF7 BTNL9 PDCD1LG2 | 2.55e-12 | 706 | 196 | 32 | IPR013783 |
| Domain | Kinase-like_dom | EPHA6 MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 FER DYRK3 DYRK2 FLT4 CAMK2A NTRK3 CAMK1G LRRK1 SIK3 TEK NUAK2 TNNI3K TIE1 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 3.20e-12 | 542 | 196 | 28 | IPR011009 |
| Domain | - | IL13RA2 IGSF6 EPHA6 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G KIRREL2 IGLL5 GHR KIRREL3 PTPRF BTNL3 PLXNA3 LRIT2 FLT4 EPM2A NRCAM NTRK3 TRIM71 BCAN TEK CD8A TIE1 CD300LG SLAMF7 BTNL9 PDCD1LG2 | 1.39e-11 | 663 | 196 | 30 | 2.60.40.10 |
| Domain | Ser/Thr_kinase_AS | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 NUAK2 TNNI3K CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 2.78e-11 | 357 | 196 | 22 | IPR008271 |
| Domain | S_TKc | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 TEK NUAK2 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 3.10e-11 | 359 | 196 | 22 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 NUAK2 TNNI3K CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 3.65e-11 | 362 | 196 | 22 | PS00108 |
| Domain | Ig-like_dom | IGSF6 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H KIRREL2 IGLL5 KIRREL3 PTPRF BTNL3 LRIT2 FLT4 NRCAM NTRK3 BCAN TEK CD8A TIE1 CD300LG SLAMF7 BTNL9 PDCD1LG2 | 1.17e-10 | 503 | 196 | 25 | IPR007110 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | MARK3 SIK1 NUAK1 CAMK2A CAMK1G NUAK2 PRKAA2 CHEK2 PNCK ULK2 DCLK1 | 1.38e-10 | 69 | 196 | 11 | IPR020636 |
| Domain | IG_LIKE | IGSF6 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H KIRREL2 IGLL5 KIRREL3 PTPRF BTNL3 LRIT2 FLT4 NRCAM NTRK3 BCAN TEK CD8A CD300LG SLAMF7 BTNL9 PDCD1LG2 | 3.97e-10 | 491 | 196 | 24 | PS50835 |
| Domain | Ig/MHC_CS | 4.34e-10 | 58 | 196 | 10 | IPR003006 | |
| Domain | IG_MHC | 6.15e-10 | 60 | 196 | 10 | PS00290 | |
| Domain | Pkinase | MARK3 PDPK1 CLK4 SIK1 TTK NUAK1 DYRK3 DYRK2 CAMK2A CAMK1G LRRK1 SIK3 NUAK2 CDK13 PRKAA2 CHEK2 PNCK MAP3K13 ULK2 DCLK1 CDK6 | 6.25e-10 | 381 | 196 | 21 | PF00069 |
| Domain | MHC_I | 1.29e-09 | 21 | 196 | 7 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.29e-09 | 21 | 196 | 7 | IPR001039 | |
| Domain | C1-set | 8.78e-08 | 54 | 196 | 8 | PF07654 | |
| Domain | IGc1 | 1.18e-07 | 56 | 196 | 8 | SM00407 | |
| Domain | - | 1.42e-07 | 24 | 196 | 6 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.42e-07 | 24 | 196 | 6 | IPR011161 | |
| Domain | Ig_C1-set | 1.56e-07 | 58 | 196 | 8 | IPR003597 | |
| Domain | MHC_I/II-like_Ag-recog | 2.58e-06 | 38 | 196 | 6 | IPR011162 | |
| Domain | 7tm_1 | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 TACR1 TBXA2R OR51A4 OR51A2 GPBAR1 HTR5A HTR6 OR5D18 FFAR3 OR2J1 HRH4 LGR6 GPR119 HRH3 OR5D13 | 2.70e-06 | 677 | 196 | 22 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 TACR1 TBXA2R OR51A4 OR51A2 GPBAR1 HTR5A HTR6 OR5D18 FFAR3 OR2J1 HRH4 LGR6 GPR119 HRH3 OR5D13 | 3.27e-06 | 685 | 196 | 22 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 TACR1 TBXA2R OR51A4 OR51A2 GPBAR1 HTR5A HTR6 OR5D18 FFAR3 OR2J1 HRH4 LGR6 GPR119 HRH3 OR5D13 | 3.76e-06 | 691 | 196 | 22 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 TACR1 TBXA2R OR51A4 OR51A2 GPBAR1 HTR5A HTR6 OR5D18 FFAR3 OR2J1 HRH4 LGR6 GPR119 HRH3 OR5D13 | 3.85e-06 | 692 | 196 | 22 | IPR000276 |
| Domain | IG | IGSF6 KIRREL2 KIRREL3 PTPRF BTNL3 LRIT2 FLT4 NRCAM NTRK3 BCAN CD8A TIE1 CD300LG SLAMF7 BTNL9 PDCD1LG2 | 9.97e-06 | 421 | 196 | 16 | SM00409 |
| Domain | Ig_sub | IGSF6 KIRREL2 KIRREL3 PTPRF BTNL3 LRIT2 FLT4 NRCAM NTRK3 BCAN CD8A TIE1 CD300LG SLAMF7 BTNL9 PDCD1LG2 | 9.97e-06 | 421 | 196 | 16 | IPR003599 |
| Domain | TRYPSIN_HIS | 1.29e-05 | 103 | 196 | 8 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.60e-05 | 106 | 196 | 8 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.71e-05 | 107 | 196 | 8 | PS00134 | |
| Domain | Peptidase_S1A | 2.55e-05 | 113 | 196 | 8 | IPR001314 | |
| Domain | GPCR_Rhodpsn_7TM | OR2C3 OR2W1 TAAR8 GPR101 CHRM2 FFAR4 OPN5 TACR1 TBXA2R OR51A4 OR51A2 GPBAR1 HTR5A HTR6 OR5D18 FFAR3 HRH4 GPR119 HRH3 OR5D13 | 2.69e-05 | 670 | 196 | 20 | IPR017452 |
| Domain | TRYPSIN_DOM | 2.89e-05 | 115 | 196 | 8 | PS50240 | |
| Domain | Tryp_SPc | 3.27e-05 | 117 | 196 | 8 | SM00020 | |
| Domain | Trypsin_dom | 4.17e-05 | 121 | 196 | 8 | IPR001254 | |
| Domain | Trypsin | 4.17e-05 | 121 | 196 | 8 | PF00089 | |
| Domain | TRYPSIN_SER | 4.51e-05 | 90 | 196 | 7 | IPR033116 | |
| Domain | Peptidase_S1_PA | 4.69e-05 | 123 | 196 | 8 | IPR009003 | |
| Domain | Pkinase_Tyr | 6.58e-05 | 129 | 196 | 8 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.06e-04 | 138 | 196 | 8 | IPR001245 | |
| Domain | V-set | 1.45e-04 | 184 | 196 | 9 | PF07686 | |
| Domain | EGF | 1.95e-04 | 235 | 196 | 10 | SM00181 | |
| Domain | FN3 | 2.60e-04 | 199 | 196 | 9 | PS50853 | |
| Domain | Ig_V-set | 2.60e-04 | 199 | 196 | 9 | IPR013106 | |
| Domain | EGF-like_dom | 3.10e-04 | 249 | 196 | 10 | IPR000742 | |
| Domain | Carb_kinase_FGGY_CS | 3.26e-04 | 3 | 196 | 2 | IPR018483 | |
| Domain | Tyr_kinase_cat_dom | 3.28e-04 | 88 | 196 | 6 | IPR020635 | |
| Domain | TyrKc | 3.28e-04 | 88 | 196 | 6 | SM00219 | |
| Domain | FN3_dom | 3.73e-04 | 209 | 196 | 9 | IPR003961 | |
| Domain | PROTEIN_KINASE_TYR | 5.54e-04 | 97 | 196 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.54e-04 | 97 | 196 | 6 | IPR008266 | |
| Domain | Glycerol_kin | 6.48e-04 | 4 | 196 | 2 | IPR005999 | |
| Domain | NADP_OxRdtase_dom | 6.94e-04 | 17 | 196 | 3 | IPR023210 | |
| Domain | Kringle_CS | 6.94e-04 | 17 | 196 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 6.94e-04 | 17 | 196 | 3 | PS00021 | |
| Domain | KR | 6.94e-04 | 17 | 196 | 3 | SM00130 | |
| Domain | Kringle | 6.94e-04 | 17 | 196 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 6.94e-04 | 17 | 196 | 3 | PS50070 | |
| Domain | Kringle | 6.94e-04 | 17 | 196 | 3 | PF00051 | |
| Domain | Aldo_ket_red | 6.94e-04 | 17 | 196 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 6.94e-04 | 17 | 196 | 3 | IPR001395 | |
| Domain | FN3 | 7.66e-04 | 185 | 196 | 8 | SM00060 | |
| Domain | EGF_3 | 8.66e-04 | 235 | 196 | 9 | PS50026 | |
| Domain | Groucho_enhance | 1.07e-03 | 5 | 196 | 2 | IPR009146 | |
| Domain | FGGY_KINASES_1 | 1.07e-03 | 5 | 196 | 2 | PS00933 | |
| Domain | Carb_kinase_FGGY_C | 1.07e-03 | 5 | 196 | 2 | IPR018485 | |
| Domain | TLE_N | 1.07e-03 | 5 | 196 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.07e-03 | 5 | 196 | 2 | IPR005617 | |
| Domain | FGGY_KINASES_2 | 1.07e-03 | 5 | 196 | 2 | PS00445 | |
| Domain | IGv | 1.15e-03 | 75 | 196 | 5 | SM00406 | |
| Domain | Carb_kinase_FGGY_N | 1.60e-03 | 6 | 196 | 2 | IPR018484 | |
| Domain | FGGY_C | 1.60e-03 | 6 | 196 | 2 | PF02782 | |
| Domain | fn3 | 1.63e-03 | 162 | 196 | 7 | PF00041 | |
| Domain | EGF | 2.15e-03 | 126 | 196 | 6 | PF00008 | |
| Domain | Carb_kinase_FGGY | 2.22e-03 | 7 | 196 | 2 | IPR000577 | |
| Domain | - | 2.22e-03 | 7 | 196 | 2 | 3.10.20.230 | |
| Domain | KA1/Ssp2_C | 2.22e-03 | 7 | 196 | 2 | IPR028375 | |
| Domain | FGGY_N | 2.22e-03 | 7 | 196 | 2 | PF00370 | |
| Domain | MFS_dom | 2.93e-03 | 134 | 196 | 6 | IPR020846 | |
| Domain | DC | 2.94e-03 | 8 | 196 | 2 | PS50309 | |
| Domain | Doublecortin_dom | 2.94e-03 | 8 | 196 | 2 | IPR003533 | |
| Domain | Cl-channel_core | 3.76e-03 | 9 | 196 | 2 | IPR014743 | |
| Domain | - | 3.76e-03 | 9 | 196 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 3.76e-03 | 9 | 196 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 3.76e-03 | 9 | 196 | 2 | IPR001807 | |
| Domain | Ig_I-set | 3.98e-03 | 190 | 196 | 7 | IPR013098 | |
| Domain | I-set | 3.98e-03 | 190 | 196 | 7 | PF07679 | |
| Domain | Kringle-like | 4.51e-03 | 32 | 196 | 3 | IPR013806 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 5.21e-13 | 9 | 152 | 7 | MM14527 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.42e-12 | 6 | 152 | 6 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.88e-12 | 7 | 152 | 6 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.88e-12 | 7 | 152 | 6 | M47530 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 4.25e-10 | 18 | 152 | 7 | MM14525 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 6.29e-10 | 11 | 152 | 6 | M525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.02e-09 | 20 | 152 | 7 | MM1374 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.25e-09 | 12 | 152 | 6 | M47529 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 6.03e-09 | 25 | 152 | 7 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 6.03e-09 | 25 | 152 | 7 | MM1465 | |
| Pathway | WP_GPCRS_NONODORANT | CHRM2 FFAR4 OPN5 GPRC5D TACR1 ADGRL3 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 FFAR3 HRH4 ADGRE5 GPR119 HRH3 | 2.85e-08 | 266 | 152 | 16 | MM15843 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H IGLL5 CD8A CD300LG SLAMF7 | 2.27e-07 | 135 | 152 | 11 | MM14781 |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 5.51e-07 | 29 | 152 | 6 | M1062 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.71e-06 | 54 | 152 | 7 | MM14871 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G PTPRF NRCAM CD8A PDCD1LG2 | 1.71e-06 | 133 | 152 | 10 | M16476 |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 2.51e-06 | 37 | 152 | 6 | M18615 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 4.69e-06 | 41 | 152 | 6 | M13519 | |
| Pathway | WP_TAR_SYNDROME | 4.92e-06 | 63 | 152 | 7 | M48082 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.42e-06 | 42 | 152 | 6 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.42e-06 | 42 | 152 | 6 | MM14971 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 6.24e-06 | 43 | 152 | 6 | M12617 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.05e-05 | 98 | 152 | 8 | M965 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.73e-05 | 76 | 152 | 7 | MM14526 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.93e-05 | 52 | 152 | 6 | M13103 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.05e-05 | 78 | 152 | 7 | M973 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.96e-05 | 56 | 152 | 6 | MM15901 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.51e-05 | 88 | 152 | 7 | M16004 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 5.32e-05 | 62 | 152 | 6 | M39639 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.06e-04 | 70 | 152 | 6 | M12294 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | TAAR8 CHRM2 GHR TACR1 TBXA2R VIPR2 HTR5A HTR6 GPR156 HRH4 HRH3 | 1.77e-04 | 272 | 152 | 11 | M13380 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.17e-04 | 190 | 152 | 9 | M8240 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | TAAR8 CHRM2 FFAR4 OPN5 TACR1 TBXA2R GPBAR1 HTR5A HTR6 FFAR3 HRH4 HRH3 | 2.41e-04 | 330 | 152 | 12 | M18334 |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | HLA-A HLA-B HLA-C PDPK1 CTSC HLA-E HLA-F HLA-G HLA-H CUL7 IGLL5 AP1G1 SPSB2 TRIM71 CD8A CD300LG SLAMF7 BTNL9 PDCD1LG2 | 2.67e-04 | 719 | 152 | 19 | MM14540 |
| Pathway | WP_ALLOGRAFT_REJECTION | 3.96e-04 | 89 | 152 | 6 | M39398 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TAAR8 CHRM2 FFAR4 OPN5 TACR1 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 FFAR3 HRH4 ADGRE5 HRH3 | 4.85e-04 | 463 | 152 | 14 | M507 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TAAR8 CHRM2 OPN5 TACR1 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 FFAR3 HRH4 ADGRE5 HRH3 | 7.75e-04 | 430 | 152 | 13 | MM15160 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | TAAR8 CHRM2 OPN5 TACR1 TBXA2R GPBAR1 HTR5A HTR6 FFAR3 HRH4 HRH3 | 9.71e-04 | 333 | 152 | 11 | MM14963 |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.00e-03 | 106 | 152 | 6 | M518 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC17A7 SLC6A15 SLC7A8 SLC6A11 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 1.11e-03 | 238 | 152 | 9 | MM15076 |
| Pathway | REACTOME_FREE_FATTY_ACID_RECEPTORS | 1.13e-03 | 5 | 152 | 2 | M27368 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.21e-03 | 74 | 152 | 5 | M48080 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | MAN2B1 HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H GM2A PLAU SLC11A1 CDK13 ADGRE5 | 1.26e-03 | 511 | 152 | 14 | MM15330 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDPK1 TRPC3 TAAR8 CHRM2 FFAR4 OPN5 TACR1 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 CAMK2A FFAR3 HRH4 ADGRE5 HRH3 | 1.49e-03 | 702 | 152 | 17 | M746 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC17A7 SLC6A15 SLC7A8 SLC6A11 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 1.52e-03 | 249 | 152 | 9 | M5988 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDPK1 TRPC3 TAAR8 CHRM2 FFAR4 OPN5 TACR1 TBXA2R GPBAR1 VIPR2 HTR5A HTR6 FFAR3 HRH4 ADGRE5 HRH3 | 1.64e-03 | 646 | 152 | 16 | MM14962 |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI | 1.68e-03 | 6 | 152 | 2 | M47883 | |
| Pathway | WP_AFLATOXIN_B1_METABOLISM | 1.68e-03 | 6 | 152 | 2 | MM15846 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE | 1.86e-03 | 23 | 152 | 3 | M39843 | |
| Pubmed | Increased hepatic iron in mice lacking classical MHC class I molecules. | 1.17e-18 | 8 | 203 | 8 | 12393413 | |
| Pubmed | 1.17e-18 | 8 | 203 | 8 | 9806638 | ||
| Pubmed | 1.17e-18 | 8 | 203 | 8 | 19752186 | ||
| Pubmed | 1.28e-17 | 14 | 203 | 9 | 9021146 | ||
| Pubmed | 5.22e-17 | 10 | 203 | 8 | 12574368 | ||
| Pubmed | 1.91e-16 | 11 | 203 | 8 | 16365422 | ||
| Pubmed | 1.91e-16 | 11 | 203 | 8 | 10377186 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.08e-16 | 7 | 203 | 7 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 2.08e-16 | 7 | 203 | 7 | 28234229 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2642506 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 9037062 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 20957233 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 2.08e-16 | 7 | 203 | 7 | 20974936 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 2.08e-16 | 7 | 203 | 7 | 2908875 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 3458188 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 19462379 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 2.08e-16 | 7 | 203 | 7 | 6300850 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 2.08e-16 | 7 | 203 | 7 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 2.08e-16 | 7 | 203 | 7 | 2906539 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 3013627 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 3894562 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 2.08e-16 | 7 | 203 | 7 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 2.08e-16 | 7 | 203 | 7 | 18383043 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8833240 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 2.08e-16 | 7 | 203 | 7 | 3025084 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 2.08e-16 | 7 | 203 | 7 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 2.08e-16 | 7 | 203 | 7 | 6786753 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6583704 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6571712 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 12006653 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 7520098 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10452993 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 26714929 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6280871 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10799615 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 2.08e-16 | 7 | 203 | 7 | 19454713 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10229092 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2879284 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 7306483 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 2.08e-16 | 7 | 203 | 7 | 1731192 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 1627536 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 2.08e-16 | 7 | 203 | 7 | 2422118 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 34181639 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 2.08e-16 | 7 | 203 | 7 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 2.08e-16 | 7 | 203 | 7 | 11894934 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 19700752 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 11894963 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 22287714 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2997361 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 9869916 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 312902 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 3335396 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6689056 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 16461341 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 2.08e-16 | 7 | 203 | 7 | 6822218 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 2.08e-16 | 7 | 203 | 7 | 19820922 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8181071 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 2.08e-16 | 7 | 203 | 7 | 6895103 | |
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 2.08e-16 | 7 | 203 | 7 | 7759137 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 2.08e-16 | 7 | 203 | 7 | 6966299 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 12140378 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 2410925 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 12421934 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 3840763 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 12421940 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 9770513 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 19195028 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 16473882 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 10479061 | ||
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 2.08e-16 | 7 | 203 | 7 | 2909618 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8168857 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 20534453 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 19342630 | ||
| Pubmed | Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs. | 2.08e-16 | 7 | 203 | 7 | 2212699 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 12817010 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 7530689 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8781130 | ||
| Pubmed | VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. | 2.08e-16 | 7 | 203 | 7 | 14630790 | |
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 1396970 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 16054612 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 8022824 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 21690324 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 7118211 | ||
| Pubmed | 2.08e-16 | 7 | 203 | 7 | 7118212 | ||
| Interaction | HLA-H interactions | 7.14e-09 | 17 | 189 | 6 | int:HLA-H | |
| Interaction | HLA-G interactions | CLSTN3 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H PLXNA3 CD8A MEGF8 | 1.48e-08 | 118 | 189 | 11 | int:HLA-G |
| Interaction | LILRB1 interactions | 1.67e-08 | 10 | 189 | 5 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.67e-08 | 10 | 189 | 5 | int:LILRB2 | |
| Interaction | HLA-E interactions | 5.42e-08 | 79 | 189 | 9 | int:HLA-E | |
| Interaction | CD8A interactions | 1.24e-07 | 26 | 189 | 6 | int:CD8A | |
| Interaction | HLA-DRB3 interactions | 2.10e-07 | 67 | 189 | 8 | int:HLA-DRB3 | |
| Interaction | HLA-F interactions | 1.64e-05 | 86 | 189 | 7 | int:HLA-F | |
| Interaction | B2M interactions | 2.55e-05 | 92 | 189 | 7 | int:B2M | |
| Interaction | SFTPC interactions | CLSTN3 PRSS8 HLA-A HLA-E HLA-F HLA-H METRN PLAU PLXNA3 MEGF8 | 4.86e-05 | 222 | 189 | 10 | int:SFTPC |
| Interaction | KLRD1 interactions | 5.63e-05 | 104 | 189 | 7 | int:KLRD1 | |
| Interaction | SLURP1 interactions | 6.55e-05 | 144 | 189 | 8 | int:SLURP1 | |
| Interaction | ITM2B interactions | 9.02e-05 | 112 | 189 | 7 | int:ITM2B | |
| Cytoband | 6p21.3 | 1.89e-06 | 250 | 202 | 9 | 6p21.3 | |
| Cytoband | 1q32.1 | 1.21e-04 | 108 | 202 | 5 | 1q32.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 2.94e-04 | 378 | 202 | 8 | chr6p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 3.21e-04 | 290 | 202 | 7 | chr1q32 | |
| Cytoband | 7q21-q22 | 8.47e-04 | 10 | 202 | 2 | 7q21-q22 | |
| GeneFamily | C1-set domain containing | 4.53e-08 | 42 | 148 | 7 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 6.35e-08 | 44 | 148 | 7 | 588 | |
| GeneFamily | Solute carriers | SLC46A1 SLC35G1 SLC17A7 SLC22A20P SLC16A9 SLC6A15 SLC35G2 SLC7A8 SLC6A11 SLC10A2 SLC11A1 SLC45A3 SLC20A2 SLC39A14 SLC2A12 | 8.86e-07 | 395 | 148 | 15 | 752 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.13e-04 | 40 | 148 | 4 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 3.51e-04 | 160 | 148 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.64e-04 | 161 | 148 | 7 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.93e-04 | 163 | 148 | 7 | 590 | |
| GeneFamily | Histamine receptors | 3.95e-04 | 4 | 148 | 2 | 187 | |
| GeneFamily | Free fatty acid receptors | 3.95e-04 | 4 | 148 | 2 | 203 | |
| GeneFamily | Glycerol kinases | 9.77e-04 | 6 | 148 | 2 | 568 | |
| GeneFamily | Immunoglobulin like domain containing | 1.07e-03 | 193 | 148 | 7 | 594 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 1.36e-03 | 7 | 148 | 2 | 285 | |
| GeneFamily | Doublecortin superfamily | 2.87e-03 | 10 | 148 | 2 | 1369 | |
| GeneFamily | Chloride voltage-gated channels | 2.87e-03 | 10 | 148 | 2 | 302 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 4.89e-03 | 13 | 148 | 2 | 170 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 6.52e-03 | 15 | 148 | 2 | 458 | |
| GeneFamily | Aldo-keto reductases | 6.52e-03 | 15 | 148 | 2 | 399 | |
| GeneFamily | Kallikreins | 7.41e-03 | 16 | 148 | 2 | 616 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.52e-11 | 16 | 201 | 7 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 6.55e-11 | 19 | 201 | 7 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 6.55e-11 | 19 | 201 | 7 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.00e-10 | 20 | 201 | 7 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.49e-10 | 21 | 201 | 7 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 4.35e-10 | 24 | 201 | 7 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 6.01e-10 | 25 | 201 | 7 | MM672 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 8.00e-10 | 41 | 201 | 8 | MM710 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SCN4A GPRC5D FFAR3 | 1.20e-09 | 86 | 201 | 10 | MM834 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 3.16e-09 | 31 | 201 | 7 | MM3729 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H TMEM229B SLC11A1 CD8A | 4.38e-09 | 98 | 201 | 10 | MM460 |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H TMEM229B SLC11A1 CD8A | 5.34e-09 | 100 | 201 | 10 | MM458 |
| Coexpression | PAL_PRMT5_TARGETS_DN | 7.87e-09 | 35 | 201 | 7 | MM674 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 1.72e-08 | 84 | 201 | 9 | MM1049 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.75e-08 | 39 | 201 | 7 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 1.75e-08 | 39 | 201 | 7 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.17e-08 | 90 | 201 | 9 | MM3756 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 3.58e-08 | 43 | 201 | 7 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 4.23e-08 | 44 | 201 | 7 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 5.84e-08 | 46 | 201 | 7 | MM3712 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 9.19e-08 | 49 | 201 | 7 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 1.06e-07 | 50 | 201 | 7 | MM3805 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 1.40e-07 | 52 | 201 | 7 | MM3808 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | GPAA1 MAN2B1 HLA-A HLA-B HLA-C ESD HLA-E HLA-F HLA-G HLA-H PTPRF CLCN6 PLAT PLXNA3 SLC20A2 LHFPL2 SLC39A14 | 1.49e-07 | 470 | 201 | 17 | MM1053 |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 1.66e-07 | 143 | 201 | 10 | MM3673 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 2.28e-07 | 82 | 201 | 8 | MM3858 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 2.37e-07 | 56 | 201 | 7 | MM3852 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 2.48e-07 | 114 | 201 | 9 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 2.68e-07 | 57 | 201 | 7 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 3.42e-07 | 59 | 201 | 7 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 3.42e-07 | 59 | 201 | 7 | MM3704 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.62e-07 | 87 | 201 | 8 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 3.85e-07 | 120 | 201 | 9 | MM3710 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 5.13e-07 | 91 | 201 | 8 | MM3720 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | HLA-B HLA-C INPP5B HLA-E HLA-F HLA-G HLA-H SIK3 CRY1 SLC11A1 ERMARD | 6.97e-07 | 209 | 201 | 11 | MM17088 |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 8.39e-07 | 97 | 201 | 8 | MM3789 | |
| Coexpression | YU_MYC_TARGETS_DN | 9.17e-07 | 68 | 201 | 7 | MM632 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 1.05e-06 | 44 | 201 | 6 | MM805 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.49e-06 | 73 | 201 | 7 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.64e-06 | 74 | 201 | 7 | MM3796 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | HLA-A HLA-B HLA-C CTSC HLA-E HLA-F HLA-G HLA-H SLC6A15 DCLK1 | 1.78e-06 | 185 | 201 | 10 | MM1072 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.79e-06 | 75 | 201 | 7 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.79e-06 | 75 | 201 | 7 | MM3718 | |
| Coexpression | DURAND_STROMA_NS_UP | 2.72e-06 | 194 | 201 | 10 | MM962 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 2.86e-06 | 52 | 201 | 6 | MM968 | |
| Coexpression | KIM_LRRC3B_TARGETS | 3.08e-06 | 30 | 201 | 5 | M17363 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 3.28e-06 | 82 | 201 | 7 | MM3777 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 4.18e-06 | 85 | 201 | 7 | MM1279 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 5.27e-06 | 88 | 201 | 7 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 5.35e-06 | 124 | 201 | 8 | MM3726 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 5.48e-06 | 58 | 201 | 6 | MM661 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 6.03e-06 | 126 | 201 | 8 | MM3709 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 6.13e-06 | 90 | 201 | 7 | MM750 | |
| Coexpression | MA_RAT_AGING_UP | 6.39e-06 | 127 | 201 | 8 | MM16096 | |
| Coexpression | JIANG_MELANOMA_TRM10_LAMINA_PROPRIA | 6.60e-06 | 91 | 201 | 7 | M48974 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 7.09e-06 | 92 | 201 | 7 | MM3748 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 7.62e-06 | 93 | 201 | 7 | MM1185 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | KLK10 HLA-A HLA-B HLA-C ESD HLA-E HLA-F HLA-G HLA-H CLCN3 PTPRF GPRC5D SLC45A3 TLE3 CHEK2 SLC39A14 AQR | 8.03e-06 | 630 | 201 | 17 | MM1038 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_PODOCYTE_AGEING | 8.97e-06 | 222 | 201 | 10 | MM3733 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 9.40e-06 | 96 | 201 | 7 | MM3834 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | MAN2B1 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SLC11A1 CD8A | 1.01e-05 | 225 | 201 | 10 | MM17079 |
| Coexpression | LIN_NPAS4_TARGETS_UP | 1.26e-05 | 183 | 201 | 9 | MM767 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 1.31e-05 | 140 | 201 | 8 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.45e-05 | 142 | 201 | 8 | MM3757 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_UP | 1.48e-05 | 20 | 201 | 4 | MM890 | |
| Coexpression | WIELAND_UP_BY_HBV_INFECTION | 1.49e-05 | 103 | 201 | 7 | M11620 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.49e-05 | 103 | 201 | 7 | MM476 | |
| Coexpression | ZHANG_UTERUS_C12_MONOCYTE | 1.57e-05 | 188 | 201 | 9 | MM16618 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 1.59e-05 | 104 | 201 | 7 | MM3812 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | HLA-A HLA-B HLA-C CYP26A1 HLA-F GPR101 CSMD2 FFAR4 GHR SLC35G1 KIRREL3 SLC17A7 TACR1 MMD2 ABTB2 ADGRL3 ALOX15 TCAF2 HTR6 BCAN SLC6A11 CD8A DCLK1 | 1.67e-05 | 1115 | 201 | 23 | M10371 |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 1.69e-05 | 145 | 201 | 8 | MM3744 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 1.86e-05 | 147 | 201 | 8 | MM3753 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 2.18e-05 | 196 | 201 | 9 | MM3746 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 2.18e-05 | 196 | 201 | 9 | MM3730 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 2.43e-05 | 111 | 201 | 7 | MM3831 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP | 2.46e-05 | 199 | 201 | 9 | M8080 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.56e-05 | 200 | 201 | 9 | M8967 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 2.89e-05 | 114 | 201 | 7 | MM3799 | |
| Coexpression | AIZARANI_LIVER_C1_NK_NKT_CELLS_1 | 3.00e-05 | 157 | 201 | 8 | M39105 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 3.89e-05 | 211 | 201 | 9 | MM17081 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_UROTHELIAL_CELL_AGEING | 4.09e-05 | 164 | 201 | 8 | MM3680 | |
| Coexpression | LEE_BMP2_TARGETS_UP | PRSS8 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CUL7 KLHL32 GHR SLC35G1 METRN PLAT ALOX15 LRRK1 TEK TIE1 | 5.24e-05 | 805 | 201 | 18 | MM1067 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | KLK10 MAN2B1 HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H CLCN3 PTPRF GPRC5D TLE3 CHEK2 SLC39A14 AQR | 5.32e-05 | 659 | 201 | 16 | MM1040 |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 5.49e-05 | 126 | 201 | 7 | MM3711 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 5.77e-05 | 127 | 201 | 7 | MM3856 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 6.73e-05 | 176 | 201 | 8 | MM1048 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 7.37e-05 | 132 | 201 | 7 | MM841 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL | 7.37e-05 | 132 | 201 | 7 | M39046 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING | 7.82e-05 | 231 | 201 | 9 | MM3741 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 8.90e-05 | 136 | 201 | 7 | MM3747 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | HLA-A HLA-B HLA-C HLA-E HLA-F HLA-G HLA-H SIK1 GM2A ABHD16A DCLK1 | 9.32e-05 | 352 | 201 | 11 | MM3788 |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 9.32e-05 | 137 | 201 | 7 | MM16612 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 9.78e-05 | 60 | 201 | 5 | M40971 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 9.82e-05 | 238 | 201 | 9 | MM3728 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 1.02e-04 | 32 | 201 | 4 | MM17 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 1.03e-04 | 187 | 201 | 8 | MM16611 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.03e-04 | 187 | 201 | 8 | MM1034 | |
| Coexpression | MEL18_DN.V1_UP | 1.12e-04 | 141 | 201 | 7 | M2784 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.15e-04 | 190 | 201 | 8 | MM3832 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS | 1.17e-04 | 142 | 201 | 7 | M40152 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000 | IGSF6 MAN2B1 HLA-C CTSC TRPC3 HLA-E RFTN1 PLAU NOS3 FLT4 NRCAM TEK TMEM229B SLC11A1 TIE1 SLC45A3 BAZ1A ADGRE5 BTNL9 AQR | 1.58e-05 | 761 | 189 | 20 | gudmap_developingKidney_e15.5_Endothelial cells_1000 |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | HLA-A HLA-B HLA-C HLA-E RFTN1 NOS3 FLT4 TEK FCN3 TMTC1 TIE1 BTNL9 | 1.05e-10 | 195 | 202 | 12 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | HLA-B HLA-C HLA-E RFTN1 FLT4 TEK FCN3 TMTC1 TIE1 CD300LG BTNL9 | 1.45e-09 | 193 | 202 | 11 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | HLA-B HLA-C HLA-E RFTN1 FLT4 TEK FCN3 TMTC1 TIE1 CD300LG BTNL9 | 1.53e-09 | 194 | 202 | 11 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | HLA-A HLA-B HLA-C HLA-E RFTN1 TEK FCN3 TMTC1 TIE1 CD300LG BTNL9 | 1.61e-09 | 195 | 202 | 11 | 50a193475db1bb1e05b8590225a553688c372c14 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HLA-A HLA-B HLA-C HLA-E HLA-F TBXA2R TEK FCN3 TIE1 CD300LG BTNL9 | 1.61e-09 | 195 | 202 | 11 | a08a3261679f89bb63ca2589d79b6deff716ccad |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | HLA-A HLA-B HLA-C HLA-E RFTN1 TEK FCN3 TMTC1 TIE1 CD300LG BTNL9 | 1.80e-09 | 197 | 202 | 11 | f9731d4d636e51b94a96805eee6afe9aedc175e3 |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-09 | 198 | 202 | 11 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-09 | 199 | 202 | 11 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | IL13RA2 HLA-A HLA-B HLA-C HLA-E PLAT TBXA2R FLT4 TEK FCN3 BTNL9 | 2.00e-09 | 199 | 202 | 11 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-09 | 200 | 202 | 11 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-09 | 200 | 202 | 11 | 9f1626a7e1bd00977a5c316cafbdf654b52bad94 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-09 | 200 | 202 | 11 | 3007583eaad3a5ae2df010513d3e4df59155123d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-08 | 187 | 202 | 10 | a555a4af7946dec14a6b176ace4a4c2ecfd7f59e | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.94e-08 | 192 | 202 | 10 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.94e-08 | 192 | 202 | 10 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.04e-08 | 193 | 202 | 10 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | HLA-A HLA-B HLA-C BTNL3 ADGRL3 TBXA2R FCN3 CD300LG ADGRE5 BTNL9 | 2.04e-08 | 193 | 202 | 10 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | HLA-A HLA-B HLA-C BTNL3 ADGRL3 TBXA2R FCN3 CD300LG ADGRE5 BTNL9 | 2.04e-08 | 193 | 202 | 10 | d4b58eee97043b4337ec36c40f9af6499d864df9 |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.14e-08 | 194 | 202 | 10 | 72749ab1dd36a0d58624328961e1db08ccba2686 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.14e-08 | 194 | 202 | 10 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.14e-08 | 194 | 202 | 10 | 81b8f60d3b81e494051721ce9b8b6aefd415442c | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.24e-08 | 195 | 202 | 10 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-08 | 196 | 202 | 10 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.47e-08 | 197 | 202 | 10 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-08 | 198 | 202 | 10 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-08 | 198 | 202 | 10 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | Transverse-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 2.59e-08 | 198 | 202 | 10 | 3b0613171cc7d5320f0b525cc6836f21874b0505 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-08 | 198 | 202 | 10 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Endoth-Vasc|World / shred by cell class for parenchyma | 2.59e-08 | 198 | 202 | 10 | 067101d070cfaf84c7d16c6e517f8946690ad502 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-08 | 199 | 202 | 10 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-08 | 199 | 202 | 10 | dfd60380a29f99e187050933ee5252ec11c68a32 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.72e-08 | 199 | 202 | 10 | 523e01f6a0abd9820697572e042a381aae8932dc | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-08 | 199 | 202 | 10 | 0d0d5cb821db16514192ad536849a8a04e22e637 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-08 | 200 | 202 | 10 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | Sigmoid-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 2.85e-08 | 200 | 202 | 10 | 2071a71b6fba403f55becddc0434d56a0b598c8e | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.33e-08 | 169 | 202 | 9 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-08 | 172 | 202 | 9 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-07 | 186 | 202 | 9 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-07 | 186 | 202 | 9 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.97e-07 | 187 | 202 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-07 | 189 | 202 | 9 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | LAM-Endothelial-VasEndo-1|LAM / Condition, Lineage and Cell class | 2.16e-07 | 189 | 202 | 9 | 454e64b1ee93edebbc1576fbf7c3a6db332fa927 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-07 | 189 | 202 | 9 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-07 | 191 | 202 | 9 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-07 | 192 | 202 | 9 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-07 | 192 | 202 | 9 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-07 | 193 | 202 | 9 | 5d42979d811ee13a07dee08a3743a90776017cb4 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-07 | 193 | 202 | 9 | 97c0730aad9135ac681250b3871cc094a28f80a7 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-07 | 193 | 202 | 9 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 194 | 202 | 9 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.69e-07 | 194 | 202 | 9 | 68e9ad254fe94e2f59cf5c2b2ea3e1245cb85104 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-07 | 194 | 202 | 9 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 194 | 202 | 9 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 194 | 202 | 9 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-07 | 195 | 202 | 9 | 667a2ed4b865e9a37674b3d154bb5bf2188b3ebf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-07 | 195 | 202 | 9 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-07 | 195 | 202 | 9 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-07 | 195 | 202 | 9 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 2.94e-07 | 196 | 202 | 9 | 2bf0f36af1d0934c03999dbbff3c51ae9432386d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 196 | 202 | 9 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-07 | 197 | 202 | 9 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 3.07e-07 | 197 | 202 | 9 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.07e-07 | 197 | 202 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 197 | 202 | 9 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 197 | 202 | 9 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.07e-07 | 197 | 202 | 9 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 197 | 202 | 9 | 8f009a15f154b3bb184b489da4722b7c27de7e11 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 197 | 202 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-07 | 197 | 202 | 9 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-07 | 198 | 202 | 9 | 715ecad21f572b195ff3b78216b1a7b32bbb4ace | |
| ToppCell | 18-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 3.20e-07 | 198 | 202 | 9 | 70d3ea0837dd6ad62abdf349e566a2e62c8e345a | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.20e-07 | 198 | 202 | 9 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-07 | 198 | 202 | 9 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 198 | 202 | 9 | 40c2171e79f578c9116d872c189f953dc61d052d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-07 | 198 | 202 | 9 | 9d03768f8b6c74e060c5f045508538f9b331f469 | |
| ToppCell | 18-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 3.20e-07 | 198 | 202 | 9 | 6b7f1b352dc3a803af87106ffb63944bd4286dfe | |
| ToppCell | distal-1-Endothelial-Capillary|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.34e-07 | 199 | 202 | 9 | 4b22769882fdd83f9cdca59e4d39ef441e62856b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 199 | 202 | 9 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-07 | 199 | 202 | 9 | 82758d0cee9387d002e3f68a6faa324134fb7564 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-07 | 199 | 202 | 9 | 5f67ea58512856cbdcef759088a5869720a947a8 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-07 | 199 | 202 | 9 | 307d29816a224193aa3d8c4540e128b2ad2e90b9 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-07 | 199 | 202 | 9 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | cellseq-Endothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.34e-07 | 199 | 202 | 9 | 4757827efb393c429adec5079d18a173baf23d74 | |
| ToppCell | distal-Endothelial-Capillary-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.34e-07 | 199 | 202 | 9 | d27fbd9a651821b2859dfa80bce4e6fc6f8299fc | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 199 | 202 | 9 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-07 | 199 | 202 | 9 | 8db1acdcabf97f01b9ca17456c48ec8ac4928390 | |
| ToppCell | proximal-Endothelial|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 202 | 9 | 970dac1b11ae8f4adb26634717064289967b4bde | |
| ToppCell | mLN-(1)_T_cell-(10)_CD8_T|mLN / shred on region, Cell_type, and subtype | 3.48e-07 | 200 | 202 | 9 | 6f02ba3a76e8aa3083efea9cb4ee587799c61fda | |
| ToppCell | proximal-3-Endothelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 202 | 9 | 90c36cfb9632a3bdc9a335b2193f6b08aba35208 | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 202 | 9 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 202 | 9 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-07 | 200 | 202 | 9 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-07 | 200 | 202 | 9 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-07 | 200 | 202 | 9 | 13f6ac0dfc9206dd2e6cbd84357a5883952ee5c7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-07 | 200 | 202 | 9 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| Computational | Genes in the cancer module 293. | 1.04e-09 | 12 | 113 | 6 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 3.31e-09 | 14 | 113 | 6 | MODULE_143 | |
| Computational | Neighborhood of INPP5D | 5.25e-06 | 43 | 113 | 6 | GNF2_INPP5D | |
| Computational | Neighborhood of PTPRC | 6.73e-06 | 68 | 113 | 7 | GNF2_PTPRC | |
| Computational | Neighborhood of HLA-C | 8.93e-06 | 47 | 113 | 6 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 8.93e-06 | 47 | 113 | 6 | GNF2_PTPN6 | |
| Computational | Neighborhood of CD48 | 1.89e-05 | 32 | 113 | 5 | GNF2_CD48 | |
| Computational | Neighborhood of CD53 | 3.06e-05 | 58 | 113 | 6 | GNF2_CD53 | |
| Computational | Neighborhood of VAV1 | 3.41e-05 | 36 | 113 | 5 | GNF2_VAV1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.71e-04 | 50 | 113 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.71e-04 | 50 | 113 | 5 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Neighborhood of STAT6 | 1.76e-04 | 79 | 113 | 6 | GNF2_STAT6 | |
| Computational | Genes in the cancer module 27. | IL13RA2 IGSF6 HLA-A HLA-B HLA-C HLA-G GHR PTPRF PTPRH TEK CD8A TIE1 | 3.44e-04 | 355 | 113 | 12 | MODULE_27 |
| Computational | Neighborhood of RAP1B | 5.26e-04 | 36 | 113 | 4 | GNF2_RAP1B | |
| Computational | Neighborhood of CD97 | 6.49e-04 | 38 | 113 | 4 | GNF2_CD97 | |
| Computational | Serine proteases. | 7.17e-04 | 39 | 113 | 4 | MODULE_109 | |
| Computational | Genes in the cancer module 107. | 1.43e-03 | 79 | 113 | 5 | MODULE_107 | |
| Drug | tert-butyl acetate | 3.75e-08 | 58 | 198 | 8 | CID000010908 | |
| Drug | meclofenamate | 1.33e-07 | 94 | 198 | 9 | CID000004036 | |
| Drug | Dimebon | 3.78e-07 | 8 | 198 | 4 | CID000197033 | |
| Drug | NSC186061 | 9.37e-07 | 118 | 198 | 9 | CID000004163 | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | IGSF6 SCN4A VIPR2 CACNA2D1 EPM2A NRCAM BCAN FCN3 SLC7A8 CELA3B DCLK1 | 1.24e-06 | 196 | 198 | 11 | 3668_UP |
| Drug | sunitinib | 2.11e-06 | 130 | 198 | 9 | CID005329102 | |
| Drug | Dietary Sucrose | SYNDIG1L PRSS8 EPHA6 TMPRSS5 GPR101 NEB CHRM2 NUAK1 GPRC5D SLC22A20P NOS3 MMD2 ADGRL3 ALOX15 FLT4 NRCAM HTR6 CAMK2A CAMK1G SLC6A11 TNNI3K CD300LG KLK13 HRH3 | 2.50e-06 | 942 | 198 | 24 | ctd:D019422 |
| Drug | ONNO | 2.60e-06 | 12 | 198 | 4 | CID006857661 | |
| Drug | diisopropylfluorophosphate | PRSS8 KLK10 ESD CTSC DPP8 CHRM2 OPN5 PLAT PLAU CAMK2A CELA3B HABP2 KLK13 | 5.11e-06 | 321 | 198 | 13 | CID000005936 |
| Drug | HOE 944 | 5.19e-06 | 14 | 198 | 4 | CID000129045 | |
| Drug | iodobolpyramine | 6.40e-06 | 5 | 198 | 3 | CID000127808 | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | CYP26A1 CLCN6 PLAT CPLANE1 TBXA2R CRYBG2 TLE3 LHFPL2 HABP2 SLAMF7 | 7.75e-06 | 193 | 198 | 10 | 5273_UP |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | SIK1 CLCN6 PTPRH PLAT TBXA2R VIPR2 CACNA2D1 EPM2A JADE2 LRRK1 | 8.11e-06 | 194 | 198 | 10 | 7379_UP |
| Drug | mepyramine | 8.47e-06 | 154 | 198 | 9 | CID000004992 | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | IGSF6 GK2 EPM2A HTR5A SLC11A1 MEGF8 CDK13 MAP3K13 SLAMF7 KCNAB3 | 9.28e-06 | 197 | 198 | 10 | 4266_UP |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | CLSTN3 INPP5B GM2A TBXA2R VIPR2 CRYBG2 CAMK1G LRRK1 MEGF8 CDK13 | 9.28e-06 | 197 | 198 | 10 | 6412_UP |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A | IL13RA2 NEB CPLANE1 CRYBG2 NRCAM BCAN RHOT2 LRRK1 NUAK2 TLE4 | 9.70e-06 | 198 | 198 | 10 | 7291_UP |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | CLSTN3 IGSF6 PTPRH TACR1 VIPR2 CRYBG2 FLT4 NTRK3 SLC6A15 MAP3K13 | 9.70e-06 | 198 | 198 | 10 | 5110_UP |
| Drug | chloride | PRSS8 PDPK1 CTSC BEST3 TMPRSS5 CHRM2 CLCN3 CLCN6 AP1G1 SCN4A SLC17A7 GM2A PLAT TACR1 NOS3 CACNA2D1 FLT4 HTR5A HTR6 SLC6A15 DPP3 SLC6A11 SLC20A2 SLAMF7 | 1.11e-05 | 1029 | 198 | 24 | CID000000312 |
| Drug | atropine sulfate | HLA-A CHRM2 CLCN3 CLCN6 TACR1 NOS3 TBXA2R VIPR2 CACNA2D1 HTR5A HTR6 HRH4 HRH3 | 1.18e-05 | 347 | 198 | 13 | CID000003661 |
| Drug | Nsc34399 | 1.27e-05 | 6 | 198 | 3 | CID000003622 | |
| Drug | Adana | 1.43e-05 | 36 | 198 | 5 | CID000117765 | |
| Drug | hydroxyzine | 1.94e-05 | 19 | 198 | 4 | CID000003658 | |
| Drug | 4-azidobenzoic acid | 1.94e-05 | 19 | 198 | 4 | CID003034184 | |
| Drug | ketanserin | 1.97e-05 | 131 | 198 | 8 | CID000003822 | |
| Drug | Piroxicam | GPAA1 HLA-A HLA-B HLA-C CTSC HLA-E HLA-G GCSH TTK CLCN3 GM2A PLAT SLC6A15 DPP3 SLC7A8 BAZ1A LHFPL2 | 2.25e-05 | 603 | 198 | 17 | ctd:D010894 |
| Drug | ZD4190 | 2.41e-05 | 20 | 198 | 4 | CID005329032 | |
| Drug | doxepin | 2.43e-05 | 40 | 198 | 5 | CID000003158 | |
| Drug | omeprazole sulfenamide | 3.51e-05 | 8 | 198 | 3 | CID000130512 | |
| Drug | hexamethonium | 3.70e-05 | 143 | 198 | 8 | CID000003604 | |
| Drug | H-8105 | TAAR8 CHRM2 SLC17A7 TACR1 NOS3 TBXA2R CACNA2D1 HTR5A HTR6 HRH4 HRH3 | 3.88e-05 | 282 | 198 | 11 | CID000164531 |
| Drug | ondansetron | 3.90e-05 | 44 | 198 | 5 | CID000004595 | |
| Drug | Amino Acids, Peptides, and Proteins | 4.36e-05 | 45 | 198 | 5 | ctd:D000602 | |
| Drug | WEB 2086 | 4.49e-05 | 108 | 198 | 7 | CID000065889 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 5.08e-05 | 193 | 198 | 9 | 3814_DN | |
| Drug | antazoline | 5.24e-05 | 9 | 198 | 3 | CID000002200 | |
| Drug | Gly-pro-na | 5.24e-05 | 9 | 198 | 3 | CID000194319 | |
| Drug | NSC-334212 | 5.24e-05 | 9 | 198 | 3 | CID000333414 | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 4634_UP | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 6203_UP | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 2732_UP | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 2486_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 5006_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 3381_UP | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 6636_DN | |
| Drug | phentolamine | 6.68e-05 | 200 | 198 | 9 | CID000005775 | |
| Drug | T15550 | 7.14e-05 | 26 | 198 | 4 | CID000005454 | |
| Drug | JP-8 | 7.14e-05 | 26 | 198 | 4 | CID000054931 | |
| Drug | R396 | 7.43e-05 | 10 | 198 | 3 | CID000164286 | |
| Drug | 2-aminobenzimidazole | 7.43e-05 | 10 | 198 | 3 | CID000013624 | |
| Drug | R 487 | 7.43e-05 | 10 | 198 | 3 | CID000131469 | |
| Drug | impentamine | 7.52e-05 | 2 | 198 | 2 | CID009793868 | |
| Drug | ZD1542 | 7.52e-05 | 2 | 198 | 2 | CID006439492 | |
| Drug | homohistamine | 7.52e-05 | 2 | 198 | 2 | CID000170389 | |
| Drug | aplysamine | 7.52e-05 | 2 | 198 | 2 | CID000362025 | |
| Drug | connessine | 7.52e-05 | 2 | 198 | 2 | CID000002860 | |
| Drug | 4-fluoro-2-(4-(4-(2-hydroxypropan-2-yl)pyrrolidin-3-ylamino)-6,7-dimethoxyquinazolin-2-yl)phenol | 7.52e-05 | 2 | 198 | 2 | ctd:C556313 | |
| Drug | VUF 8328 | 7.52e-05 | 2 | 198 | 2 | CID010176414 | |
| Drug | SC-359 | 7.52e-05 | 2 | 198 | 2 | CID000022970 | |
| Drug | iodophenpropit | 7.52e-05 | 2 | 198 | 2 | CID003035746 | |
| Drug | immethridine | 7.52e-05 | 2 | 198 | 2 | CID009989505 | |
| Drug | Cipralisant [inn] | 7.52e-05 | 2 | 198 | 2 | CID006433105 | |
| Drug | phenoxytoluene | 7.52e-05 | 2 | 198 | 2 | CID000070352 | |
| Drug | imbutamine | 7.52e-05 | 2 | 198 | 2 | CID013499360 | |
| Drug | proxyfan | 7.52e-05 | 2 | 198 | 2 | CID006421522 | |
| Drug | JNJ7777120 | 7.52e-05 | 2 | 198 | 2 | CID004908365 | |
| Drug | burimamide | 7.52e-05 | 2 | 198 | 2 | CID003032915 | |
| Drug | piperidine-1-carbothioamide | 7.52e-05 | 2 | 198 | 2 | CID001551232 | |
| Drug | methimepip | 7.52e-05 | 2 | 198 | 2 | CID011313836 | |
| Drug | AC1O46V6 | 7.52e-05 | 2 | 198 | 2 | CID006400683 | |
| Drug | alpha-methylhistamine | 9.65e-05 | 28 | 198 | 4 | CID000003615 | |
| Drug | furazan | 1.02e-04 | 11 | 198 | 3 | CID000067517 | |
| Drug | phenylmethylsulfonyl fluoride | 1.08e-04 | 263 | 198 | 10 | CID000004784 | |
| Drug | serotonin | PDPK1 GPR101 CHRM2 CLCN3 CLCN6 SLC17A7 TACR1 TBXA2R CACNA2D1 HTR5A HTR6 SLC6A15 SLC6A11 HRH4 HRH3 | 1.08e-04 | 554 | 198 | 15 | CID000005202 |
| Drug | U-37883A | 1.11e-04 | 29 | 198 | 4 | CID000064392 | |
| Drug | mianserin | 1.13e-04 | 87 | 198 | 6 | CID000004184 | |
| Drug | methacholine | 1.25e-04 | 217 | 198 | 9 | CID000001993 | |
| Drug | idazoxan | 1.28e-04 | 89 | 198 | 6 | CID000054459 | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 1.35e-04 | 12 | 198 | 3 | ctd:C578491 | |
| Drug | norclozapine | 1.37e-04 | 57 | 198 | 5 | CID000002820 | |
| Drug | AC-680 | 1.63e-04 | 93 | 198 | 6 | CID000004691 | |
| Drug | dimethindene | 1.74e-04 | 13 | 198 | 3 | CID000021855 | |
| Drug | furoxan | 1.74e-04 | 13 | 198 | 3 | CID000001756 | |
| Drug | 5,7-DHT | 1.86e-04 | 33 | 198 | 4 | CID000038368 | |
| Drug | amsonine | 1.92e-04 | 181 | 198 | 8 | CID000002866 | |
| Drug | cyproheptadine | 1.94e-04 | 96 | 198 | 6 | CID000002913 | |
| Drug | Aldehydes | DCDC1 HLA-B CYP26A1 HLA-F KIRREL2 NEB SVEP1 PLAT TBXA2R CRYBG2 JADE2 SLC6A15 TMTC1 CD8A HABP2 SLAMF7 DCLK1 | 1.96e-04 | 720 | 198 | 17 | ctd:D000447 |
| Drug | taurine | 1.99e-04 | 231 | 198 | 9 | CID000001123 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.00e-04 | 182 | 198 | 8 | 4376_DN | |
| Drug | L-655,240 | 2.20e-04 | 14 | 198 | 3 | CID000122070 | |
| Drug | chloropyramine | 2.20e-04 | 14 | 198 | 3 | CID000025294 | |
| Drug | AC1MHZPD | 2.20e-04 | 14 | 198 | 3 | CID003035635 | |
| Drug | otilonium bromide | 2.20e-04 | 14 | 198 | 3 | CID000072092 | |
| Drug | 1,5-diphenyl-3-dimethylaminopyrrolidine | 2.24e-04 | 3 | 198 | 2 | CID003016476 | |
| Drug | imetit | 2.24e-04 | 3 | 198 | 2 | ctd:C077430 | |
| Drug | Da-4626 | 2.24e-04 | 3 | 198 | 2 | CID000134179 | |
| Drug | DA 4360 | 2.24e-04 | 3 | 198 | 2 | CID000134176 | |
| Drug | HOE 166 | 2.24e-04 | 3 | 198 | 2 | CID000195130 | |
| Drug | McN-6186 | 2.24e-04 | 3 | 198 | 2 | CID000196758 | |
| Drug | Lupitidinum | 2.24e-04 | 3 | 198 | 2 | CID000051670 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 5.20e-13 | 7 | 194 | 6 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | TRPC3 HLA-E HLA-G CHRM2 SLC17A7 GPRC5D TACR1 NOS3 VIPR2 HTR5A CAMK2A CRY1 MTHFD1 DCLK1 | 3.70e-06 | 477 | 194 | 14 | C0005586 |
| Disease | Malignant Glioma | 6.91e-06 | 70 | 194 | 6 | C0555198 | |
| Disease | mixed gliomas | 6.91e-06 | 70 | 194 | 6 | C0259783 | |
| Disease | high grade glioma (is_marker_for) | 8.15e-06 | 42 | 194 | 5 | DOID:3070 (is_marker_for) | |
| Disease | Glioma | 2.43e-05 | 87 | 194 | 6 | C0017638 | |
| Disease | Metastatic melanoma | 2.84e-05 | 54 | 194 | 5 | C0278883 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | HLA-A HLA-B HLA-C CYP26A1 ETFDH HLA-G FFAR4 TACR1 SIK3 CD300LG | 3.92e-05 | 307 | 194 | 10 | EFO_0004612, EFO_0020946 |
| Disease | Parapsoriasis en Plaques | 4.30e-05 | 2 | 194 | 2 | C0162442 | |
| Disease | – | 4.30e-05 | 2 | 194 | 2 | 608579 | |
| Disease | Intracranial Embolism and Thrombosis | 4.30e-05 | 2 | 194 | 2 | C0007781 | |
| Disease | Erythroderma, Maculopapular | 4.30e-05 | 2 | 194 | 2 | C0014799 | |
| Disease | Cerebral Embolism and Thrombosis | 4.30e-05 | 2 | 194 | 2 | C0877855 | |
| Disease | Parakeratosis Variegata | 4.30e-05 | 2 | 194 | 2 | C0030437 | |
| Disease | Brain Embolism and Thrombosis | 4.30e-05 | 2 | 194 | 2 | C0936247 | |
| Disease | Parapsoriasis | 4.30e-05 | 2 | 194 | 2 | C0030491 | |
| Disease | Cholesterol Embolism | 4.30e-05 | 2 | 194 | 2 | C0149649 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 4.30e-05 | 2 | 194 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 4.30e-05 | 2 | 194 | 2 | cv:CN077964 | |
| Disease | Posterior Choroidal Artery Infarction | 4.44e-05 | 11 | 194 | 3 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 4.44e-05 | 11 | 194 | 3 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 4.44e-05 | 11 | 194 | 3 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 4.44e-05 | 11 | 194 | 3 | C0751011 | |
| Disease | Subcortical Infarction | 4.44e-05 | 11 | 194 | 3 | C0751014 | |
| Disease | Cerebral Infarction | 4.44e-05 | 11 | 194 | 3 | C0007785 | |
| Disease | beta-2 microglobulin measurement | 4.44e-05 | 11 | 194 | 3 | EFO_0005197 | |
| Disease | Takayasu arteritis | 5.83e-05 | 148 | 194 | 7 | EFO_1001857 | |
| Disease | Pulmonary Thromboembolisms | 5.89e-05 | 12 | 194 | 3 | C0524702 | |
| Disease | Pulmonary Embolism | 5.89e-05 | 12 | 194 | 3 | C0034065 | |
| Disease | monocyte percentage of leukocytes | HLA-A HLA-B HLA-C MARK3 CYP26A1 ETFDH DPP8 PTPRH ABHD16A CRYBG2 JADE2 CELA3B SLC45A3 TLE3 CDK6 | 1.07e-04 | 731 | 194 | 15 | EFO_0007989 |
| Disease | Arterial Occlusive Diseases | 1.28e-04 | 3 | 194 | 2 | C0003838 | |
| Disease | Abruptio Placentae | 1.28e-04 | 3 | 194 | 2 | C0000832 | |
| Disease | glycerol kinase deficiency (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:0060363 (implicated_via_orthology) | |
| Disease | cholesterol in large HDL measurement | 1.88e-04 | 80 | 194 | 5 | EFO_0021900 | |
| Disease | angiopoietin-1 receptor measurement | 2.51e-04 | 19 | 194 | 3 | EFO_0010600 | |
| Disease | Alzheimer disease type 1 | 2.56e-04 | 4 | 194 | 2 | cv:C1863052 | |
| Disease | ALZHEIMER DISEASE, FAMILIAL, 1 | 2.56e-04 | 4 | 194 | 2 | 104300 | |
| Disease | vulva cancer (is_implicated_in) | 2.56e-04 | 4 | 194 | 2 | DOID:1245 (is_implicated_in) | |
| Disease | occupational asthma (is_implicated_in) | 2.56e-04 | 4 | 194 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 2.56e-04 | 4 | 194 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Schizophrenia | HLA-A HLA-B HLA-C HLA-E CSMD2 CHRM2 EML5 SLC17A7 PLAT VIPR2 HTR5A HTR6 NTRK3 SLC6A11 MTHFD1 DCLK1 | 2.60e-04 | 883 | 194 | 16 | C0036341 |
| Disease | Hypertensive disease | 2.75e-04 | 190 | 194 | 7 | C0020538 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.93e-04 | 144 | 194 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | Posterior Fossa Hemorrhage | 4.24e-04 | 5 | 194 | 2 | C0751893 | |
| Disease | allergic asthma (is_implicated_in) | 4.24e-04 | 5 | 194 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | neuronal ceroid lipofuscinosis 3 (implicated_via_orthology) | 4.24e-04 | 5 | 194 | 2 | DOID:0110731 (implicated_via_orthology) | |
| Disease | level of T-cell surface glycoprotein CD8 alpha chain in blood serum | 4.24e-04 | 5 | 194 | 2 | OBA_2040238 | |
| Disease | peritonitis (is_implicated_in) | 4.24e-04 | 5 | 194 | 2 | DOID:8283 (is_implicated_in) | |
| Disease | Intracranial Hemorrhage | 4.24e-04 | 5 | 194 | 2 | C0151699 | |
| Disease | Endometrioid carcinoma ovary | 4.24e-04 | 5 | 194 | 2 | C0346163 | |
| Disease | optic disc size measurement | 4.34e-04 | 205 | 194 | 7 | EFO_0004832 | |
| Disease | Acute Cerebrovascular Accidents | 4.43e-04 | 54 | 194 | 4 | C0751956 | |
| Disease | parental longevity | HLA-A HLA-B HLA-C HDX GPANK1 ZC3HC1 TRIM71 TNNI3K TMTC1 ADGRE5 PDCD1LG2 | 4.58e-04 | 494 | 194 | 11 | EFO_0007796 |
| Disease | Parkinson's disease (implicated_via_orthology) | 6.21e-04 | 157 | 194 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | angiopoietin-1 receptor, soluble measurement | 6.34e-04 | 6 | 194 | 2 | EFO_0008023 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.20e-04 | 291 | 194 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | Cerebrovascular accident | 7.50e-04 | 62 | 194 | 4 | C0038454 | |
| Disease | Hereditary Diffuse Gastric Cancer | 7.53e-04 | 293 | 194 | 8 | C1708349 | |
| Disease | squamous cell lung carcinoma | 8.05e-04 | 165 | 194 | 6 | EFO_0000708 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 8.12e-04 | 28 | 194 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | tuberculosis (is_implicated_in) | 8.12e-04 | 28 | 194 | 3 | DOID:399 (is_implicated_in) | |
| Disease | Stomach Neoplasms | 8.21e-04 | 297 | 194 | 8 | C0038356 | |
| Disease | pulmonary hypertension (is_marker_for) | 8.46e-04 | 64 | 194 | 4 | DOID:6432 (is_marker_for) | |
| Disease | Malignant neoplasm of stomach | 8.76e-04 | 300 | 194 | 8 | C0024623 | |
| Disease | bipolar disorder (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | retinopathy of prematurity (is_implicated_in) | 8.84e-04 | 7 | 194 | 2 | DOID:13025 (is_implicated_in) | |
| Disease | osteopetrosis (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 8.84e-04 | 7 | 194 | 2 | cv:CN043596 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 9.01e-04 | 29 | 194 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 9.01e-04 | 29 | 194 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 9.01e-04 | 29 | 194 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 9.01e-04 | 29 | 194 | 3 | C0014518 | |
| Disease | Stevens-Johnson Syndrome | 9.97e-04 | 30 | 194 | 3 | C0038325 | |
| Disease | Alzheimer disease | 1.17e-03 | 8 | 194 | 2 | cv:C0002395 | |
| Disease | Hypoxemia | 1.32e-03 | 33 | 194 | 3 | C0700292 | |
| Disease | Hypoxia | 1.32e-03 | 33 | 194 | 3 | C0242184 | |
| Disease | Anoxemia | 1.32e-03 | 33 | 194 | 3 | C0003129 | |
| Disease | Anoxia | 1.32e-03 | 33 | 194 | 3 | C0003130 | |
| Disease | cervical carcinoma | 1.33e-03 | 182 | 194 | 6 | EFO_0001061 | |
| Disease | IGA Glomerulonephritis | 1.44e-03 | 34 | 194 | 3 | C0017661 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.50e-03 | 9 | 194 | 2 | DOID:988 (is_implicated_in) | |
| Disease | kallikrein-11 measurement | 1.50e-03 | 9 | 194 | 2 | EFO_0010573 | |
| Disease | Nephritis | 1.50e-03 | 9 | 194 | 2 | C0027697 | |
| Disease | autism spectrum disorder, schizophrenia | 1.52e-03 | 327 | 194 | 8 | EFO_0003756, MONDO_0005090 | |
| Disease | Behcet's disease (is_implicated_in) | 1.70e-03 | 36 | 194 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 1.84e-03 | 37 | 194 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | Brain hemorrhage | 1.87e-03 | 10 | 194 | 2 | C0553692 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.15e-03 | 200 | 194 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.33e-03 | 274 | 194 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.42e-03 | 276 | 194 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.48e-03 | 41 | 194 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.48e-03 | 41 | 194 | 3 | C0858252 | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 2.53e-03 | 86 | 194 | 4 | EFO_0008407 | |
| Disease | hexanoylcarnitine measurement | 2.72e-03 | 12 | 194 | 2 | EFO_0021040 | |
| Disease | Congenital myopathy (disorder) | 2.72e-03 | 12 | 194 | 2 | C0270960 | |
| Disease | Thromboembolism | 2.72e-03 | 12 | 194 | 2 | C0040038 | |
| Disease | Memory Loss | 2.85e-03 | 43 | 194 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 2.85e-03 | 43 | 194 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 2.85e-03 | 43 | 194 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 2.85e-03 | 43 | 194 | 3 | C0751293 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSLLFGYDWVGIPLV | 221 | Q8N1M1 | |
| ETGKCPALYWLSGLT | 41 | P10768 | |
| GGWAHVVCALYIPEV | 81 | P55198 | |
| CISPGLFDVLTWLGY | 296 | P50406 | |
| LKNITPSDIGLYGCW | 101 | Q6UXE8 | |
| VLGLWNGCEYFVLAP | 421 | Q6UXG8 | |
| VLTCGGLLLVFYWRP | 41 | Q4VNC0 | |
| LCKSNGWILPTVYQG | 156 | Q8NHP1 | |
| LCKSNGWILPTVYQG | 156 | O95154 | |
| GCRIAFLYWPLLESA | 416 | Q9BQT9 | |
| IWGEYGCPLRLDFTE | 746 | Q5SY80 | |
| LSCAWVIEAQPGYPI | 776 | Q7Z408 | |
| SGRLYAGPEVDIWSC | 186 | P54646 | |
| AGPEVDIWSCGVILY | 191 | P54646 | |
| CVSTPLEAGYSVLGW | 296 | O95870 | |
| STRWLCLIGYGVPLL | 651 | P48960 | |
| IGVSTYLCLAPDGIW | 526 | Q9HAR2 | |
| RLLTGCVGGSVWYLE | 11 | Q12887 | |
| DWNLCTVFGILLGYP | 166 | Q96LT6 | |
| LGPVVCDLWLALDYV | 91 | P08172 | |
| IGLYCQPGIDLPSWI | 61 | Q4L235 | |
| YATPVDLWSVGCIFA | 196 | Q00534 | |
| CVVPDWLHDIILGYG | 681 | O60306 | |
| CDIYIWAPLAGTCGV | 181 | P01732 | |
| WSLGVILFICLSGYP | 411 | O96017 | |
| PQLTCILKGDWLGLY | 471 | Q8NEG7 | |
| LWVETFLPNDCLLYG | 266 | Q9Y485 | |
| YTPAIDVWSCGCILG | 891 | Q14004 | |
| VWSCAVTGRPGLTYQ | 51 | Q9NRL2 | |
| QYLLCSWKPGIGVLL | 151 | Q14627 | |
| LLGTVFLLCPYWGEL | 6 | Q6UY27 | |
| LTCQATGYPLAEVSW | 141 | Q9BQ51 | |
| SLAAYGWQLTCVLPT | 396 | Q14699 | |
| TLRCWALGFYPAEIT | 221 | P30511 | |
| VTDLIGLPWVCFIYT | 521 | Q8TD20 | |
| RCWALGFYPAEITLT | 226 | P01893 | |
| LCVLLVVGSYAWGVS | 141 | Q8NGL1 | |
| PLVCNRTLYGIVSWG | 221 | Q9UKR3 | |
| SLWSEPVVCGIGLAI | 441 | Q9UHI5 | |
| PLVQVAAWCIGEYGD | 471 | O43747 | |
| RCWALGFYPAEIILT | 226 | P17693 | |
| CSPGWLADGSVRYPI | 301 | Q96GW7 | |
| PDWTCIVVGFTSGYV | 151 | Q9H2M9 | |
| ATLSGWYHLCLPEGR | 101 | O75636 | |
| CYGSPLAVGVLYIEW | 26 | Q7RTY1 | |
| YVSCGELWINPDLSI | 1001 | M0R2J8 | |
| LWGPEKTISYAGCTV | 86 | Q9GZK6 | |
| YELSTPLCWDSKLIG | 291 | Q96NT5 | |
| TISAWIYGLGLCGLF | 66 | Q8IY49 | |
| NLVDGVYCLPIGHWI | 116 | O95278 | |
| TLRCWALGFYPAEIT | 221 | P13747 | |
| YQISGNLTVPWITGC | 416 | Q7Z353 | |
| CVGLYVASLLGQPWL | 126 | Q9HCP6 | |
| LCRPWGVSVDKEGYI | 606 | Q2Q1W2 | |
| YWEPSARGIICGLTQ | 371 | Q14409 | |
| NAPLCVLSYVAGIAW | 21 | O43292 | |
| YLLGRGAAWVGVCEL | 161 | O95872 | |
| VWLDYVGSVLACPAN | 21 | Q16288 | |
| ECIAEGLPTPIIYWA | 291 | Q92823 | |
| CAEGAVEWLYPAGAL | 51 | Q9UJH8 | |
| WYSNGPGLLVIDCAS | 1706 | Q38SD2 | |
| CVVLLAVPVGAYAWA | 471 | A6NDA9 | |
| AWLIFADGLLYCPVA | 776 | Q9HBX8 | |
| CWGPYVATLLLSVLA | 236 | Q8TDU6 | |
| WAAGVITYILLCGFP | 571 | O15075 | |
| YGILKVPTGSWLCRT | 231 | Q9NQC1 | |
| LIWGYSAVAALPLCV | 161 | Q5NUL3 | |
| RCWALGFYPAEITLT | 226 | P10321 | |
| CYRGEGTLALPWLLN | 356 | P51805 | |
| WGPDKTISYVGCIIQ | 86 | Q9Y3N9 | |
| LWGPDKTISYVGCAI | 91 | Q8NHA6 | |
| LPCLEQGSYGWTVTV | 206 | A8MUP2 | |
| GISPLGWLLDQYLEC | 1061 | Q14999 | |
| VAGACIAGLWLVSYL | 121 | Q8TDV5 | |
| LICAGFLIAWIPYAV | 256 | Q6U736 | |
| GPGLSYCVWVVSATE | 1296 | Q7Z7M0 | |
| CSVFDLLGIPLYHGW | 226 | Q8N5J2 | |
| CYRWVEGNGVLSLPE | 96 | P16050 | |
| LILYPAGWGCQKAID | 151 | Q6ZUX7 | |
| FAWLGVVPLTACRIY | 101 | O60337 | |
| AWYGGLAVLLQTSPE | 41 | Q9NY33 | |
| ILGCLFGPAALYIWA | 351 | P49279 | |
| PGLVNKSCYEDGWLI | 131 | P23434 | |
| SLGPYCFLAVLAVWV | 411 | Q96P66 | |
| GLEYAHIWISIPICS | 21 | Q8NGJ7 | |
| GLEYAHIWISIPICS | 21 | Q8NGJ6 | |
| LWGPQKTISYGGCVV | 86 | Q8N628 | |
| RYSGWPAEIQIEGCI | 216 | P58499 | |
| RCWALGFYPAEITLT | 226 | P01889 | |
| DCWSIGVITYILLCG | 201 | Q96NX5 | |
| DGLGPLHYGVCSTWL | 966 | P29474 | |
| WALGVISYILLCGYP | 196 | Q6P2M8 | |
| GCLRPVWNIIGKAYS | 136 | O43283 | |
| IVSWGLECGKRPGVY | 526 | Q14520 | |
| CEPQTYGIGLKELWV | 266 | Q16134 | |
| ACWTYGISVPSGLFV | 476 | P51797 | |
| CLISDFYPGAVTVAW | 136 | B9A064 | |
| GACTLSVTQPWYLEV | 26 | O95976 | |
| YWEPSARGILCGLTQ | 371 | Q14410 | |
| LITPSGCIFLWEYLE | 131 | Q9H799 | |
| IWIPYCIKLTSNGGT | 121 | P10912 | |
| DYFLLCDAEGPWGII | 11 | Q9NZD1 | |
| CGGVSGLNPSLWYII | 1071 | P54289 | |
| FGILLWETFSLGVCP | 746 | P16591 | |
| PYIVSWCLNLRVLDG | 221 | Q8IW35 | |
| IAGAPVTLWIFYDTG | 776 | Q6V1X1 | |
| VVVADPQAGGSCIWY | 1556 | Q8N1P7 | |
| IRCVYILDPWFAGSS | 31 | Q16526 | |
| CGESPAWRIYVTLLS | 251 | O14843 | |
| TPANCTYLDLLGTWV | 26 | P53634 | |
| PYWEPSARGIICGLT | 376 | P32189 | |
| VISLAPLLFGWGETY | 171 | P47898 | |
| LPNETPCYITGWGRL | 151 | P08861 | |
| KWCLGLSVYTIPSIG | 396 | Q6GMR7 | |
| RCWALGFYPAEITLT | 226 | P04439 | |
| AVIVSIFGLCWAPYT | 361 | Q9Y5N1 | |
| YARQLAAGWGPCEVL | 461 | O00754 | |
| GPEVDVWSLGVILYT | 231 | P27448 | |
| GCNSALVTWPGYATI | 161 | P32019 | |
| SPVLLGIVWTFLSCG | 46 | Q8NFN8 | |
| CYNPLTGIWSEVCPL | 561 | Q5VTJ3 | |
| ARLPCALGAYWGLVQ | 41 | Q6UWL6 | |
| TLLCAIPEYDGFVLW | 66 | Q8IZU9 | |
| QWLSCGERGLLVYPE | 166 | O43174 | |
| TCVSGLEVNGIWPKY | 501 | Q05BV3 | |
| GLDYWGSVRLLGPVC | 61 | Q5T6L9 | |
| QPCDVWSIGCILIEY | 356 | Q9HAZ1 | |
| LGCKGPLVWSYLQLA | 161 | A6NK97 | |
| ATPVWLLFYGGVGIC | 531 | Q08357 | |
| GRPSAVEVWGYGLLC | 146 | Q15043 | |
| WSLGCILAELLTGYP | 406 | Q92630 | |
| WIKPGAIVIDCGINY | 226 | P11586 | |
| SVTGAAWYLAVLCPV | 186 | O14569 | |
| YSTPIDIWSFGCILA | 386 | O43781 | |
| YPLCSLWVTFAIGSV | 821 | Q3KNS1 | |
| DQYWPARGTETCGLI | 1461 | P10586 | |
| LVAGSYTWGIVCSLI | 146 | Q8NGL4 | |
| CPGGTASNILAYWVD | 106 | Q12908 | |
| LWIIGTIFPVAGYSL | 226 | Q12908 | |
| WLVPLGRCICSTGYE | 256 | Q9UF33 | |
| KIGVGSVTWYPLACG | 276 | O43448 | |
| CFWLTVGVYILGILG | 141 | P0DMU2 | |
| AILLGVFAVCWAPYS | 306 | Q9H3N8 | |
| AGLWIKIPCTDYIGS | 91 | P17900 | |
| QLAVEAWYRPSCLLG | 61 | A6NDD5 | |
| FLSYPTWGLVVCVSL | 611 | Q9H2J7 | |
| TYVCGGSLISPCWVI | 206 | P00749 | |
| AWELYHRTECPLGGL | 326 | Q8IYR2 | |
| SLVANWLGYSELGPI | 1111 | P35499 | |
| CISVSWILPLTYSGA | 151 | Q969N4 | |
| ITLEYAVPWFCGALI | 116 | Q8NBD8 | |
| VSCLWGGLLYVIVPK | 606 | A6NFQ2 | |
| TEAGRLPLHGYLCQW | 351 | Q8IXI1 | |
| IPLDGETWSYLIAIC | 311 | Q8TBE7 | |
| WALGCIIYQLVAGLP | 266 | O15530 | |
| YTVVGITLWASEIPG | 216 | P25103 | |
| GGPLVCYLPSAWVLV | 276 | A8MTI9 | |
| DIWSLGVVLYVLVCG | 206 | A0A0B4J2F2 | |
| DIWSLGVVLYVLVCG | 206 | P57059 | |
| IWSLGVVLYVLVCGA | 246 | Q9Y2K2 | |
| GAPLVLAGEDCLWYL | 21 | Q96DD7 | |
| GTLCQWSTLSYPGLV | 41 | Q86YJ6 | |
| WSTLSYPGLVKELCA | 46 | Q86YJ6 | |
| TPFWAGIIVCLVAYL | 86 | Q14714 | |
| GPEVDSWALGVLLYT | 231 | O60285 | |
| LVEGVTYPACHGIWS | 181 | Q9P2U7 | |
| LCVCWSPDGKYIVTG | 266 | Q8TBZ3 | |
| GKPVDLWACGVILYI | 191 | Q9UQM7 | |
| YTGPEVDSWSLGVLL | 226 | Q9H093 | |
| PLSCPVEGLWYLTGI | 241 | Q16651 | |
| LPNGLWSGSESYCRV | 421 | Q4LDE5 | |
| GGCLGYLLPAIDWDT | 171 | Q96JT2 | |
| ELWGVLQPYEHLICG | 276 | Q8N961 | |
| TLVEDPAGCVWGVAY | 51 | Q8WUX2 | |
| LLWGCLLLPGYEALE | 6 | Q6UXG3 | |
| GVGFCATLYTWLKLP | 101 | Q6ZU45 | |
| PAGIGVYSAIWQLCL | 491 | P51790 | |
| WCEVGADCITPGLYA | 561 | P51790 | |
| YALVCQALGIPIGDW | 571 | O75443 | |
| ELSPLVCAKYGWVTV | 96 | Q86WB0 | |
| TGYCWCVLVDTGRPL | 266 | Q9H4F8 | |
| LQLPDWTECELSGYG | 436 | P00750 | |
| TVILLPYVSKVTGWC | 216 | Q9BSA9 | |
| PVTLCYDWQVGSIPL | 331 | Q8IUR5 | |
| SQIFSLGYCPTGEWL | 661 | Q04727 | |
| VLLWEIVSLGGTPYC | 1041 | P35590 | |
| VTWSPCGQYLAAGSI | 236 | O75717 | |
| DLLICTYPKAGTTWI | 41 | O00338 | |
| GRTLYPAVSAVWGQC | 196 | Q99619 | |
| GVLLWEIFSLGASPY | 1101 | P35916 | |
| AGVGSWLLVLYLCPA | 61 | Q9H3S3 | |
| EIIGLGNVWRFPYLC | 66 | P48066 | |
| WTPVGVLTSLAYCLH | 11 | Q9NPH0 | |
| IYILWQLTGSAASGP | 11 | Q9NQ25 | |
| VLLWEIVSLGGTPYC | 1026 | Q02763 | |
| QIFSLGYCPTGEWLA | 661 | Q04726 | |
| FLAYLLIGWGLPTVC | 241 | P41587 | |
| LPTVCIGAWTAARLY | 251 | P41587 | |
| DLWSIGTVIYQCLVG | 196 | Q8IYT8 | |
| VRAYDPAALCGLVWT | 111 | Q6ZT12 | |
| ISPKSDVWSLGCILY | 711 | P33981 | |
| SVLGEWSLPYCGLDR | 271 | Q2M3R5 | |
| VQYPGSWCFLTLGAE | 176 | P21731 | |
| YALCLWEILTGEIPF | 651 | Q59H18 | |
| VDGLGPGSLYTCSVW | 86 | Q9HD43 | |
| GLGPGSLYTCSVWVE | 266 | Q9HD43 | |
| LCWELLYLLGAGPVE | 6 | A0A0A0MS03 | |
| LAIGYWIAPCSRLGK | 351 | Q13507 | |
| LVGGYSIWTNEPLAC | 551 | Q96NJ5 | |
| DETLQGILSWGVYPC | 236 | O43240 | |
| LKGIGCYVWDTPQIL | 4606 | P20929 | |
| LKGIGCYVWDTPEIL | 4851 | P20929 |